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Background: The Veterans Health Administration (VHA) encourages depression 
screening and treatment for pregnant veterans; however, rates of depression symptoms 
and treatment utilization during pregnancy have not been well-studied. 
Methods: We used data from the Maternity Care Coordination for Women Veterans 
cohort study. Specifically, our aims were to: 1) examine rates and correlates of 
depression symptoms in a sample of pregnant veterans; 2) understand mental health care 
treatment utilization and explore the experiences of veterans accessing mental health care 
at the VHA during pregnancy; and 3) examine VHA mental health provider's 
perspectives on depression screening and treatment in the perinatal period.  
Findings: Depression symptoms were present in 28% of pregnant veterans in our sample. 
Social support and employment decreased odds of symptoms; history of anxiety, 
antidepressant use, and active duty service resulted in increased odds of symptoms. 
Nearly 70% of women veterans with prenatal depression symptoms received at least one 
mental health visit or antidepressant prescription during pregnancy. However, 
symptomatic pregnant women without a history of depression were less likely to receive 
care. Mental health providers identified absence of screening protocols and referral 
procedures and variability in risk/benefit conversations surrounding antidepressant use as 
areas of weakness for VHA mental health care during the perinatal period. 
Conclusions: Depression symptoms were present in nearly one in every three pregnant 
veterans. Depression treatment during pregnancy is complex, requiring individualized 
vi 
care. Policies for depression screening, referrals to providers, and medication review 
could be better encouraged to improve standardized care across the VHA. 
vii 
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CHAPTER I: INTRODUCTION 
 
Pregnant Veterans receiving Care from the Veterans Health Administration  
Women represent a growing proportion of veterans utilizing Veterans Health 
Administration (VHA) care. Between 2001 and 2010, the number of women veterans 
under age 45 receiving services from the VHA nearly doubled,1 and the number of 
women receiving VHA benefits is projected to increase further over the next couple of 
decades.2  Additionally, the number of reproductive-aged women veterans utilizing VHA 
benefits to pay for maternity care increased from 12.4 to 17.8 deliveries per 1,000 women 
veterans from 2008 to 2012.3  
Despite increasing numbers, women veterans continue to be a numerical minority 
within the VHA, and it is not cost-effective to employ obstetricians to provide onsite 
maternity care for pregnant veterans. Instead, nearly all maternity care for veterans is 
provided by the Veterans Affairs (VA) Community Care program, which pays for 
prenatal and maternity care coverage at community-based obstetrical providers.3–5 
However, a substantial proportion of veterans continue to receive mental health care 
within the VHA during their pregnancies.6 This receipt of care from both VHA providers 
and community obstetricians creates a fragmented system that may be difficult for 
pregnant veterans to navigate.  
In an effort to encourage care for co-morbid conditions, such as depression, while 
simultaneously receiving obstetrical care, the VHA issued Handbook 1330.03 with 
maternity health care guidelines as a tool to manage these challenging systems.4 
Depression screening, diagnosis, and referrals for care are recommended for all pregnant 
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veterans within these maternity care guidelines.4 However, to date, little research has 
been conducted to evaluate the application of these guidelines and the relationship 
between successful management of mental health care and quality prenatal care for 
pregnant veterans. 
 
Perinatal Depression among Veterans 
Perinatal depression encompasses depressive disorders developing during 
pregnancy and occurring up to one year postpartum.7,8 In the general population, 
incidence rates of perinatal depression are as high as 1 in 5.9,10 A 2005 systematic review 
of 59 studies found prevalence rates of 8.5-11% for perinatal depression;8 however, 
prevalence estimates within high-risk populations have been estimated to be upwards of 
25%,8–13 with as high as 50% reported.14 Perinatal depression has been associated with 
behavior problems and cognitive delays in infants, compromised care giving practices, 
reduced rates of breastfeeding, maternal sleep problems, and greater suicidal ideation 
compared to women without depressive symptoms.15,16 Risk factors for perinatal 
depression include maternal anxiety, life stress, history of depression, lack of social 
support, unintended pregnancy, and relationship factors.17,18 
Estimates of rates of depression in women veterans prior to pregnancy range from 
10-60%.6,19 Roughly half of young female veterans return from military service with 
some form of disability1 and conditions such as depression, pain, and PTSD.19–21 
Depression is the most commonly diagnosed medical condition among women veterans 
ages 18-44.22 In 2012, a quarter of women veterans utilizing VHA services were 
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diagnosed with depression and 12.3% of women veterans were diagnosed with a major 
depressive disorder.22 This is in contrast to an estimated 9.3% of women ages 18-39 in 
the general U.S. population diagnosed with depression between 2009-2012.23 Women 
veterans are more likely than male veterans to be diagnosed with depression and to use 
mental health services within the VHA.24 Women veterans themselves have identified 
depression care as a high priority issue within the VHA; a survey of women veterans 
found that improving access to depression care ranked as the highest priority among 15 
mental health services.25  
Despite high rates of depression among women veterans, depression during 
pregnancy has not been well-studied in this population. . Pregnant veterans, especially 
those who have served in Operation Enduring Freedom or Operation Iraqi Freedom 
(OEF/OIF), have higher rates of depression compared to women veterans who are not 
pregnant.6,26 However, these rates are based on ICD-9CM or CPT diagnosis codes rather 
than well-validated self-report measures and likely underestimate the true prevalence of 
depression during pregnancy in veterans.6 Women veterans are uniquely challenged by 
combat-related exposures, military sexual trauma, and post-deployment stressors, all of 
which may increase the risk for developing perinatal depression compared to the general 
population.24 Higher rates of psychiatric conditions, such as post-traumatic stress 
disorder, may also increase the risk of developing perinatal depression.24  
 
Depression Treatment and Management during Pregnancy 
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It is unclear how women veterans navigate depression treatment during 
pregnancy. However, care coordination within the VHA has the potential to help 
pregnant veterans bridge gaps between dual health systems for their care. The Agency for 
Healthcare Research and Quality defines care coordination as "the deliberate organization 
of patient care activities between two or more participants involved in a patient’s care to 
facilitate the appropriate delivery of healthcare services"27 to "achieve safer and more 
effective care."28 Standards of practice for maternity care within the VHA are specified  
in Handbook 1330.03, which includes the scope of work for each position involved in the 
maternity coordination model that is expected to be applied consistently at all facilities.4 
The VHA model was instituted to bridge the gap between the existing dual VHA/non-
VHA healthcare systems and designed to "ensure that eligible women Veterans have 
access to timely prenatal care…(and) seamless coordination of non-VA maternity care 
with VA care, especially in cases of women Veterans with co-morbid conditions who 
may require VA care during their pregnancy."4 Depression screening, assessment, 
diagnosis, and treatment (both counseling and referrals to further care), are included as 
components of the maternity health care guidelines. VHA Handbook 1330.03 specifies 
that "VA providers must screen all pregnant and postpartum women for depression 
utilizing an appropriate screening tool, and have a system to ensure that positive 
screening results are followed by accurate diagnosis, implementation of treatment, and 
follow-up either within the practice or through referral."4 The VA/Department of Defense 
(DoD) Clinical Practice Guideline for the Management of Pregnancy is referenced for 
further details on specific screening tools and referral processes. Depression screenings in 
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the VA/DoD guidelines are recommended to be conducted “using a standardized tool 
such as the Edinburgh Postnatal Depression Scale or the 9-item Patient Health 
Questionnaire periodically during pregnancy and postpartum,” with periodic screening 
defined as once each in the first trimester, third trimester, and postpartum.29 However, it 
is still unknown how many women veterans experience depression symptoms during 
pregnancy and what proportion of those women receive VHA mental health care during 
their pregnancies. It is also unclear whether VHA providers utilize care coordination 
within their facility or with obstetrical providers outside their facility to facilitate 
screening and treatment for perinatal depression.  
Our primary focus was to understand the rates and correlates of depression and 
the utilization of mental health care and depression management during pregnancy in 
women veterans receiving care within the VHA healthcare system, within the context of 
VA guidelines in Handbook 1330.03.4  
 
Specific Aims 
To achieve our objectives, we conducted a mixed methods analysis of qualitative 
and quantitative data obtained from the Maternity Care Coordination for Women 
Veterans cohort study, conducted in 15 VHA hospitals across the US (VA HSR&D 
IIR13-81). This mixed methods study is the first to prospectively examine depression 
symptoms and treatment utilization among a sample of pregnant veterans across several 
VHA facilities in the US, as well as receive the perspectives of VHA mental health 
providers working with perinatal veterans. The specific aims of this dissertation were: 
CHAPTER I 
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Aim 1: To examine rates of perinatal depression symptoms in pregnant veterans: 
• Estimate the prevalence of depression symptoms in a sample of pregnant 
veterans using the Edinburgh Postnatal Depression Scale (EPDS). 
• Examine patient-level correlates of depression symptoms, including 
pregnancy factors, history of co-morbid conditions, and military-related 
characteristics. 
Aim 2: To evaluate the rate of mental health care treatment utilization during 
pregnancy and to understand the experience and management of depression in a 
sample of pregnant veterans: 
• Identify differences in treatment utilization during pregnancy by women 
veterans who report past diagnoses of depression compared to those with 
no past diagnosis.  
• Explore the decisions women veterans make regarding antidepressant use 
during pregnancy. 
• Examine whether pregnant veterans discuss medication risk counseling 
with their VHA and/or obstetrical providers. 
Aim 3: Explore the experiences of VHA mental health providers within the 
context of policy recommendations for seamless care coordination and treatment 
management for pregnant and postpartum veterans: 
• Understand typical mental health care and treatment experiences for 




• Examine if care coordination occurring at and within VHA facilities 
promotes consistent care for veterans in VHA mental health care and 
non-VHA obstetrical care.  
 
 Overview of Study Population and Data Sources 
 All data was obtained from the Maternity Care Coordination for Women Veterans 
project (VA HSR&D IIR13-81), as part of the Center for Maternal & Infant Outcomes & 
Research in Translation (COMFORT) study at the VA Central Western Massachusetts. 
Pregnant women veterans and mental health providers were enrolled into the study from 
15 VHA sites across the US (Figure 1.1). These 15 sites were purposively chosen to 
represent facilities that 1) provide a mix of delivery rate, based on prior work3 identifying 
the number of deliveries per facility to women veterans utilizing VHA benefits (high: 
>150 deliveries/year; medium: 50-149 deliveries/year; low: <50 deliveries/year); 2) allow 
for regional diversity; 3) encourage racial diversity of women veteran participants; and 4) 
have membership in the Women's Practice-Based Research Network, a VA-funded 
network of VHA facilities that provide care for a substantial number of women veterans 
and have lead site investigators willing to support COMFORT recruitment.  
 Pregnant veterans receiving care at one of the 15 preselected VHA sites were  
contacted following their VHA pregnancy confirmation visit (a visit required to initiate 
the start of VHA maternity care benefits4) and invited to participate in COMFORT. This 
sample of pregnant veterans provided the data for Aims 1 and 2 (Chapters II and III). 
Eligible participants were 1) currently pregnant; 2) a veteran (not in active duty); 3) 
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receiving maternity care through VHA benefits and/or another insurance plan (e.g., 
private insurance, Medicaid); and 4) English speaking. No participants were under the 
age of 18 because this is the youngest age of enlistment; there were no additional 
exclusion criteria.  
Contact information for veterans confirmed to be pregnant was shared with 
COMFORT research staff by local site investigators. Pregnant veterans were invited to 
participate in COMFORT via mailed recruitment packets that included an invitation 
letter. These invitation letters described the study and invited the veteran to opt-in by 
calling a toll-free number to receive further information. Research team members 
followed up with telephone calls to potential participants who did not respond to the 
study invitation. If eligibility criteria were met, two telephone surveys were scheduled 
with the woman veteran: one during the second or third trimester (ideally around 20-24 
weeks of gestation) and a second within three months after delivery. Participants were 
reimbursed $50 for each survey. This dissertation utilizes data collected during the first 
survey (i.e., during pregnancy).  
The telephone survey collected data on sociodemographic characteristics, military 
service, health status, healthcare utilization, social support, and pregnancy related factors. 
The 10-item Edinburgh Postnatal Depression Scale (EPDS) was also administered.30 
Study data were collected and managed using REDCap (Research Electronic Data 
Capture), a secure, web-based application designed to support data capture for research 
studies.31 Additionally, electronic health record (EHR) data on service-connected 
disability status, date of birth, past medical diagnoses, healthcare utilization, and 
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antidepressant prescriptions were obtained on our participants from VA Corporate Data 
Warehouse (CDW) administrative data. The CDW is a repository of data updated nightly 
from the VHA electronic medical records system for operations and research use.32 
COMFORT was approved by the Veterans Administration Central Institutional 
Review Board (CIRB) and was given a waiver of written consent so that signed consent 
forms were not required from participants. Our sample for Chapters II and III included 
participants enrolled within the first two years of COMFORT (January 28, 2016 – 
February 6, 2018), when the initial enrollment goal of 500 participants was met.  
VHA mental health providers affiliated with the enrollment sites and who were 
involved in the care of perinatal women veterans provided the data for Aim 3 (Chapter 
IV). Our sample was purposively selected, with the goal to interview at least one, but 
ideally two or more, mental health providers at each of the COMFORT study sites. The 
local site investigators for the COMFORT study provided contact information for 
potential mental health providers at their respective site; additionally, several mental 
health providers were referred to COMFORT research staff directly by interviewees. 
After receiving mental health provider contact information, COMFORT research staff 
connected with mental health providers via email to provide information on the study, the 
topics to be covered, and to schedule interviews. The interview guide utilized for the 
study (Appendix 4.1) was developed by COMFORT investigators and refined after pilot 








CHAPTER II: RATES AND CORRELATES OF DEPRESSION SYMPTOMS IN 
A SAMPLE OF PREGNANT VETERANS RECEIVING VETERANS HEALTH 




BACKGROUND: Depression is the most commonly diagnosed medical condition 
among women veterans ages 18-44; however, depression during pregnancy has not been 
well-studied in this population.  
METHODS: Pregnant veterans were recruited from 15 Veterans Health Administration 
sites across the US; our sample included 501 participants. Sociodemographic 
characteristics, military service, health status, and pregnancy related factors, as well as 
the Edinburgh Postnatal Depression Scale (EPDS) were collected as part of a telephone 
survey. Additional data were obtained from electronic health record data. We used 
multivariable logistic regression models to examine factors associated with an EPDS 
score suggestive of clinically significant depressive symptoms (≥10). 
FINDINGS: Prenatal EPDS ≥10 were calculated for 28% of our sample. Our final model 
indicated that veterans having spousal or partner support during pregnancy decreased 
odds of an EPDS ≥10 by 65% compared to veterans reporting no spousal or partner 
support. Veterans reporting being employed reduced the odds of an EPDS ≥10 by 60% 
compared to those reporting being unemployed, a homemaker, or a student. A past 
diagnosis of anxiety, past antidepressant use, and active duty service all resulted in 
increased odds of an EPDS ≥10. 
CONCLUSIONS: This is the first quantitative estimate of depression symptoms in 
pregnant veterans. The prevalence of depression symptomology was greater than the high 
end of prevalence estimates in the general pregnant population. Given that the risk of 
depression increases during the postpartum period, women who can be identified with 
depressive symptomatology during pregnancy can be offered critical resources and 






Depression is the most commonly diagnosed medical condition among women 
veterans ages 18-44.22 In 2012, close to 40,000 (25%) women veterans utilizing VHA 
services were diagnosed with depression and 12.3% of all women veterans were 
diagnosed with a major depressive disorder.22 This is in contrast to an estimated 9.3% of 
women ages 18-39 in the general U.S. population diagnosed with depression between 
2009-2012.23  
In general, 1 in 7 women experience depression in pregnancy and the postpartum 
period thus making depression the most common complication of pregnancy.33 Yet 
despite a higher likelihood of depression among women veterans outside of pregnancy, 
compared to the general population,22 depression during pregnancy has not been well-
studied. Pregnant veterans, especially those who have served in Operation Enduring 
Freedom, Operation Iraqi Freedom, and Operation New Dawn (OEF/OIF/OND), have 
higher rates of depression compared to OEF/OIF/OND women veterans who are not 
pregnant.6 However, these rates are based on ICD-9CM or CPT diagnosis codes rather 
than well-validated self-report measures and thus likely underestimate the true prevalence 
of depression during pregnancy in veterans.6  
Women veterans, compared to women in the general population, are uniquely 
challenged by combat-related exposures, military sexual trauma, and post-deployment 
stressors in addition to higher rates of other psychiatric conditions, such as post-traumatic 
stress disorder.24,34 These factors may increase the occurrence of existing or new onset 




pregnancy or within the first postpartum year, is associated with poor obstetrical 
outcomes such as low birthweight and preterm birth, as well as long-term consequences 
on the mother-infant relationship, compromised care giving practices, reduced rates of 
breastfeeding, increased sleep problems, and suicidal ideation.15,16,33 Suicide is the most 
common cause of maternal morbidity in depressed women and exceeds both postpartum 
hemorrhage and hypertensive crisis as a cause of maternal mortality in general.33,35 
Despite this, it is woefully underdiagnosed and even when recognized, undertreated.36 
Taken together, this indicates great need for both comprehensive mental health and 
prenatal care for pregnant veterans. 
Pregnant veterans receive nearly all maternity care from obstetrical providers 
outside of the VHA system, paid for under the auspices of the VA Community Care 
program.3 However, a substantial proportion of veterans continue to receive mental 
health care within the VHA during their pregnancies.6 Previous work has shown that 
veterans utilizing their VA prenatal benefits have higher rates of depression compared to 
pregnant women veterans who are eligible for these benefits but opt to use other 
insurance methods during pregnancy.37 Depression screening by VA providers has been 
recommended for all pregnant veterans,4 however, to date, little research has been 
conducted to quantify depressive symptomatology among pregnant veterans or to 
determine associations between depression symptoms and patient characteristics.  
 The goal of this analysis was to examine the prevalence and correlates of 




military-related characteristics among a sample of pregnant veterans receiving healthcare 
within the VHA system.  
 
METHODS 
Study Design, Data Source, and Study Sample 
Data were obtained from a larger cohort study, the Center for Maternal & Infant 
Outcomes & Research in Translation (COMFORT). Pregnant veterans were recruited 
from 15 VHA sites across the US. Eligible participants were 1) currently pregnant; 2) a 
veteran (not in active duty); 3) receiving maternity care through VHA benefits or another 
insurance plan (e.g., private insurance, Medicaid); and 4) English speaking. No 
participants were under the age of 18 because this is the youngest age of enlistment; there 
were no additional exclusion criteria.  
Veterans were identified as being pregnant at one of the study sites by local study 
coordinators during pregnancy consults; this data was recorded by the veteran’s VHA 
provider. All veterans confirmed to be pregnant were invited to participate in COMFORT 
via mailed recruitment packets that included an invitation letter to call to opt-in to the 
study. These invitation letters described the study and invited the veteran to call a toll-
free number to receive further information. Research team members followed up with 
telephone calls to potential participants who did not respond to the study invitation. If 
eligibility criteria were met, two telephone surveys were scheduled with the woman 
veteran: one during the second or third trimester (ideally around 20-24 weeks of 




$50 for each survey. This paper utilizes data collected during the first survey (i.e., during 
pregnancy). Enrollment rates were roughly 40%; of the 1,410 eligible women who were 
sent invitation letters, 562 had agreed to participate at the time of this analysis.  
As part of the telephone survey, information was collected about 
sociodemographic characteristics, military service, health status, healthcare utilization, 
social support, and pregnancy related factors. The 10-item Edinburgh Postnatal 
Depression Scale (EPDS) was also administered.30 Study data were collected and 
managed using REDCap (Research Electronic Data Capture), a secure, web-based 
application designed to support data capture for research studies.31 COMFORT was 
approved by the Veterans Administration Central Institutional Review Board (CIRB) and 
was given a waiver of written consent by the CIRB so that signed consent forms were not 
required from participants.  
Additionally, electronic health record (EHR) data on service-connected disability 
status, date of birth, and past medical diagnoses was obtained on our participants from 
Veterans Affairs (VA) administrative data. Service-connected disability status is 
determined by the Veteran Benefits Administration and measured as a percentage from 
0% to 100%, where 0% is the lowest level of disability and is different from not having a 
disability.1 
 Our sample included participants enrolled within the first two years of the study 
(January 28, 2016 – February 6, 2018) and until the enrollment goal of 500 participants 





Definition of Outcome 
We dichotomized our sample by EPDS score as <10 and ≥10, where higher scores 
indicate clinically significant  depressive symptoms.38 The EPDS has been validated as a 
screening tool for use in a pregnant population with a cut-off score of ≥10 determined to 
be an optimal cut-off point for detecting depression symptoms during pregnancy, with 
sensitivity, specificity, and positive predictive values of 70%, 96%, and 39%, 
respectively, at 24 weeks of pregnancy.38 The American College of Obstetricians and 
Gynecologists (ACOG) recommends the use of the EPDS during pregnancy for its ease 
in administration, its ability to capture anxiety symptoms, and its exclusion of symptoms 
of depression that are also frequent during pregnancy (such as sleep-related changes).33  
EPDS scores were totaled during the interview. For EPDS scores ≥10 and/or if the 
veteran answered “yes” to the self-harm question (EPDS Item 10), a suicide crisis 
protocol was developed in consultation with the VA Office of Suicide Prevention. In 
brief, the interviewer provided the veteran with a warm transfer to the VA Crisis Line and 
additionally asked if they would like help in getting connected to mental health resources 
at their local VA site. If yes, an email requesting help and follow-up was sent to the Local 
Site Investigator (LSI), who then took over contact with the veteran and helped set up 
additional mental health care as needed. As this discussion between the interviewer and 
veteran remained confidential, no data were available regarding completed crisis hotline 
calls or local site follow-up with these participants.  
 




We selected potential correlates of depression symptoms based on previous 
literature on predictors of depression symptoms during pregnancy,17 suggested military-
related correlates,24 and available data collected in the COMFORT survey. Data used in 
this analysis included self-reported sociodemographic characteristics (age, marital status, 
race, ethnicity, sexual orientation, employment status, urban/rural status, number of 
adopted/biological children living at home, health insurance); military service (years of 
service, deployment status, OEF/OIF/OND status, branch, component, service-connected 
disability status, history of military sexual trauma (MST)); medical history (past mental 
health diagnoses, receipt of an anti-depressant prescription prior to the current pregnancy, 
report of currently having a VA primary care provider); and pregnancy related factors 
(past pregnancy outcomes, contraceptive use at time of conception, fertility treatment 
utilization, prenatal care history, social support during pregnancy, receipt of VA 
maternity care coordination services). The military sexual trauma (MST) questions were 
adapted from the VHA’s universal MST screening questions, which have been described 
previously.39 OEF/OIF/OND status included any veteran who served in any of those 
specific military tours. Urban/rural status referred to the geographic region associated 
with each participants zip code and the FY15 VA Planning Systems Support Group 
(PSSG) file, which assigns each veteran a “U” (urban), “R” (rural), or “HR” (highly 
rural) value based on their home residence. For zip codes appearing with more than one 
URH code in the PSSG file, the code with the highest frequency of veterans for the zip 




Several variables from the EHR data were used in place of survey variables due to 
the expected reliability of the EHR data over the survey data. Age was calculated from 
birth date, which was not collected during the survey but is included in the EHR data, and 
interview date obtained from the survey data. OEF/OIF/OND service and service-
connected status were obtained from the EHR. As in previous analyses,40 we 
dichotomized presence of service-connected disability as yes (>0%) or no.  
 
Analytic Approach 
 We first examined bivariate relationships between sociodemographic 
characteristics, military service, health status, and pregnancy related variables with EPDS 
score group. Student’s t-tests and chi-squared tests were used to examine differences 
between EPDS groups and continuous factors and categorical factors, respectively.  
Next we computed multivariable logistic regression models to examine the 
likelihood of higher EPDS scores, retaining variables from bivariate analyses that were 
statistically significant at the α=0.05 level. We collapsed several multi-category variables 
for the models, including marital status (married vs. not), race (white vs. non-white), 
component (active vs. National Guard/Reserves/civilian), and military sexual trauma (yes 
vs. no). Combining categories did not change the statistical significance in bivariate 
analyses; we combined all categories of non-white race because cell counts were low 
among individuals who identified as a race other than white.  
Our final model consisted of the variables from our initial multivariable model 




remove variables, starting with the least significant, refitting subsequent models until all 
predictors were significant. Adjusted odds ratios (aOR) and 95% confidence intervals 
(CI) for each included factor are reported. Model fit was assessed with Hosmer-
Lemeshow tests. We evaluated multicollinearity prior to running our models using a 
correlation matrix of all potential included factors and condition indices. Although 
multicollinearity was not found, to identify potential overlap in the included correlates we 
ran several sensitivity analyses with models including ever diagnosis of depression and 
receipt of past antidepressant prescriptions as a combined variable and combining history 
of mental health disorders in different ways, including depression history in this variable, 
excluding depression history from this variable but retaining it as a separate variable in 
the model, and excluding depression history completely from the model.  
To examine the potential of site clustering, we conducted a generalized linear 
mixed model in the form of a hierarchical logistic regression model (using the GLIMMIX 
procedure in SAS), using the variables from our final logistic model, to account for the 
clustering of patients within each of the 15 study sites, where each study site is treated as 
a random variable.41  
We assumed that missing data were missing completely at random (MCAR) or 
missing at random (MAR) and not missing based on presence of depression symptoms. 
However, to examine the potential effect of missing data in our sample, we ran a 
sensitivity analysis using multiple imputation methods with PROC MI to impute values 








Our sample of pregnant veterans included 501 women with complete prenatal 
interviews; 142 (28%) with an EPDS score ≥10 suggestive of clinically significant 
depressive symptoms and 359 (72%) with an EPDS score <10. Those showing depressive 
symptomology had mean EPDS scores of 14.7 (+/- 4.0) with a range from 10 to 26 (data 
not shown). Participants were on average 23 weeks gestation and 31 years of age at the 
time of the survey. Over half of participants were white, married, and currently 
employed; however, more women with an EPDS <10 were married compared to those 
with an EPDS ≥10 (70% vs. 51%, p=0.02). Women with EPDS <10 were more likely to 
be employed compared to women with an EPDS ≥10 (p<0.0001) (Table 2.1). 
On average, participants served six years in the military. Over 90% were 
OEF/OIF/OND veterans, correlating with the ages of participants. About half of women 
in both EPDS groups served in the Army compared to any other branch in the military. 
Some military characteristics differed slightly by EPDS group. Women with an EPDS 
≥10 were less likely to have been deployed in the past (p=0.06) but more likely to have 
been in active duty as their most recent component in the military compared to women 
with EPDS <10 (p=0.0061). Women with an EPDS ≥10 were more likely to have a 




military sexual trauma or receiving counseling for military sexual trauma (p<0.0001) 
(Table 2.1).  
Mental health status differed significantly between EPDS groups. Women with an 
EPDS score ≥10 were significantly more likely to report ever being prescribed anti-
depressants (82% vs. 47%, p<0.0001) and to report ever being diagnosed with a past 
mental health condition (91% vs. 63%, p<0.0001) (Table 2.1). Over half of women with 
an EPDS ≥10 reported plans to continue seeing a mental health provider during their 
pregnancy, with over 90% of these women reporting planning to see a VA specific 
mental health provider. Close to a quarter of women in the EPDS <10 group also reported 
plans to continue seeing a mental health provider during pregnancy. Women with an 
EPDS score ≥10 scored significantly worse on all question compared to women with an 
EPDS <10 (data not shown). 
Obstetrical history was similar between EPDS groups; most women had been 
previously pregnant (64%) and had received their first prenatal appointment for the 
current pregnancy between 9-12 weeks of pregnancy (45%). The vast majority of 
pregnant veterans had received some VA maternity care coordination services (77%). 
Nearly all participants reported receiving some form of social support during pregnancy; 
however, more women in the EPDS <10 group indicated partner specific support 
compared to those in the EPDS ≥10 group (95% vs. 82%, p<0.0001) (Table 2.1).  
Our primary multivariable model included marital status, race, employment 
status, military component, service-connected disability status, report of military sexual 




drug abuse or alcoholism, self-reported past antidepressant prescription, and ever 
diagnosis of the following mental health conditions: depression, PTSD, anxiety, mood 
disorder, or bipolar disorder. The backward selection process removed bipolar disorder, 
marital status, PTSD, military sexual trauma, mood disorder, race, drug abuse or 
alcoholism, depression, and service-connected disability status, respectively. Hosmer-
Lemeshow tests for our final model indicated good model fit (p=0.8338). A review of 
condition indices did not indicate collinearity in our final model. The final model 
included 413 (82%) participants with full (non-missing) data. Missing correlates were 
imputed in sensitivity analyses, and results were generally consistent (data not shown). 
Our final model indicated that among pregnant veterans, having support from a 
spouse or partner resulted in a 65% decreased odds of an EPDS ≥10 compared to 
veterans reporting no spousal or partner support. Employment was also protective, with 
veterans reporting employment at the time of the prenatal interview having a reduction in 
odds of an EPDS ≥10 of 60% compared to those reporting being unemployed or a 
homemaker or student. A past diagnosis of anxiety resulted in a 2.5 times increased odds 
of an EPDS ≥10 (95% CI: 1.43-4.50). Similarly, receipt of a past antidepressant 
prescription (prior to the most recent pregnancy) was associated with higher EPDS 
symptomology compared to never receiving a past anti-depressant prescription (aOR: 
3.27; 95% CI: 1.71-6.24). Pregnant veterans most recently serving in active duty were 
nearly twice as likely to score an EPDS ≥10 compared to National Guard, Reserves, or 
civilian government employee veterans (aOR: 1.91; 95% CI: 1.08-3.37) (Table 2.2). 






 To the best of our knowledge, this study is the first to quantify depression 
symptoms and identify correlates during pregnancy within a sample of veterans. In our 
sample of pregnant veterans, 28% scored a 10 or higher on the EPDS, suggesting 
presence of depression symptoms. This is the first quantitative estimate of depression 
symptoms in pregnant veterans, and it is greater than the high end of the 20-25% 
prevalence estimates of depression in the general pregnant population.8,10 Given that the 
onset of over half of perinatal depression cases occur prior to the postpartum period,11 
women who can be identified as depressed or at-risk for depression during pregnancy can 
be offered critical resources and support prior to birth.11,42  
Our findings are similar to previous work which has found depression prevalence 
estimates of 25% in women veterans ages 18-44,1 although over half of all of our study 
participants reported ever being diagnosed with depression. Among those with EPDS 
scores ≥10, past diagnoses of mental health conditions were high, with over 90% 
reporting being diagnosed with a mental health condition. This is in line with previous 
findings on the relationship between pre-pregnancy mental health diagnoses and higher 
EPDS scores among pregnant veterans.43 A recent review of perinatal depression among 
military women (i.e., active-duty servicewomen or spouses of active-duty servicemen) 
found that prevalence of depression symptoms during pregnancy and postpartum ranged 




that our estimates are consistent with studies in similar populations, although ours 
focused on specifically the pregnancy period.44  
Accordant with hypotheses of potential factors unique to pregnant veterans that 
may increase symptoms of depression, we found that previous active-duty status 
increased the odds of depression symptoms, after adjustment for key sociodemographic 
factors.24 Additionally, we found a relationship between military sexual trauma and 
prenatal depression symptoms. MST has been shown to be associated with increased 
odds of PTSD, anxiety, depression, and substance use disorders.45 Previous work has also 
shown a connection between employment and depression in women veterans, where 
higher levels of social and financial support have been associated with lower levels of 
depression in female veterans after deployment46 and unemployed female veterans screen 
positive for depression more often than employed female veterans.47 More non-white 
women in our sample scored an EPDS ≥10 compared to white women in bivariate 
analyses. This is in contrast to previous work that did not find differences between racial 
and ethnic groups and prevalence of depression in non-pregnant veteran samples.48–50 
Most of the women in our sample with an EPDS ≥10 and many of those in the 
EPDS<10 group reported plans to visit a mental health provider during their pregnancy; 
for nearly all of these women, this mental health care would be obtained within the VHA. 
This suggests that many pregnant veterans plan to remain engaged within the VHA 
system while also receiving prenatal care from a community provider. This receipt of 
care from both VHA mental health providers and non-VHA obstetricians can create a 




any collaboration between VHA mental health and community obstetric providers occurs 
and whether information about mental health status is clearly transmitted to obstetricians 
who may need to make specific care decisions for women with depression during 
pregnancy. Maternity care coordination has been mandated by the VHA (see VHA 
Handbook 1330.034) as a tool to help pregnant veterans manage their care via maternity 
care coordinators who have the ability to link veterans to needed treatment.1,51 However, 
it is still unknown how women veterans manage depression symptoms during pregnancy 
and what treatment strategies they utilize. Future research focusing on depression 
treatment utilization during pregnancy will help clarify how well care is being 
coordinated between providers and if veterans are receiving the treatment they need 
during pregnancy. Pregnancy may be an ideal time to focus on treatment strategies, prior 
to the birth of the baby. 
We note several limitations with our study. Because we utilized an opt-in strategy, 
our overall enrollment rate was relatively low considering the number of invitation letters 
sent, and thus we may be underestimating the number of depressed pregnant veterans 
because those experiencing more depression symptoms may have been less likely to 
participate. However, our response rate is similar to a previous telephone survey 
conducted in a sample of women veterans ages 18-44, and in comparison to this 
nationally representative sample, our sample was similar with respect to age distribution, 
race, past mental health diagnoses, and military sexual trauma experience.52 Phone 
interviews may be more likely to encourage responder bias, where the participant may 




symptomatic) on the EPDS. We were also unable to control for the timing of past mental 
health diagnoses or diagnoses recorded outside of VHA care. It is possible that the timing 
of the first diagnosis may play a role in determining depression symptoms in this 
population, and whether primary depression diagnoses occurring after military service 
ends (i.e., recorded in the VHA database) are more or less likely to predict symptoms of 
depression during pregnancy compared to diagnoses occurring before military 
enrollment. Next, our findings are likely not generalizable to a broader population outside 
of English-speaking pregnant veterans receiving their care within the VA medical system. 
Finally, EPDS cannot be used as a diagnosis tool, only as a means of identifying 
depression symptomology.  
Our study also has a number of strengths, including a large sample size. Our study 
sample was diverse and was comprised of veterans from VA sites across the country. We 
were able to collect information on a wide-range of sociodemographic, military, 
pregnancy-related, and health-related factors in our telephone survey, which may not 
have been possible via other means of data collection. Likewise, responses to the EPDS 
were complete and available for 100% of our participants. 
 
CONCLUSIONS 
Our work is the first to quantify the rate of depression symptoms among a sample 
of pregnant veterans using a validated self-report depression screener. The prevalence of 
depression symptomology was greater than the high end of prevalence estimates in the 




postpartum period, women who can be identified with depressive symptomatology during 
pregnancy can be offered critical resources and support prior to birth. 
 
IMPLICATIONS FOR PRACTICE AND/OR POLICY 
This work is crucial given the rapid growth in the population of young women 
veterans and the need for quality prenatal and mental health care during pregnancy. Our 
study provides data that highlights the need for depression screening among pregnant 
veterans and identifies several key risk factors. Subsequent research should focus on 
treatment utilization patterns among pregnant veterans to understand types and 












Estimated Age (Mean ± SD, Range) 
31.9 ± 4.4 
(20.4-48.7) 
31.4 ± 4.5 
(22.6-41.7) 
0.24 
Marital Status (N, %)   
0.02 
Single 57 (15.9) 32 (22.5) 
Married 251 (69.9) 72 (50.7) 
Divorced 22 (6.1) 11 (7.7) 
Separated 4 (1.1) 5 (3.5) 
Widowed 1 (0.3) 0 (0.0) 
Missing/Unknown 24 (6.7) 22 (15.5) 
Race: White (N, %) 236 (65.7) 74 (52.1) 0.0047 
Race: Black (N, %) 71 (19.8) 45 (31.7) 0.0044 
Race: Other (N, %) 57 (15.9) 26 (18.3) 0.51 
Hispanic or Latino/Latina (N, %) 63 (17.5) 22 (15.5) 0.56 
Sexual Orientation (N, %)   
0.32 
Heterosexual 341 (95.0) 133 (93.7) 
Lesbian/gay/bisexual/asexual 11 (3.1) 7 (4.9) 
Missing/Unknown 7 (1.9) 2 (1.4) 
Urban/Rural Status (N, %)   
0.87 
Urban 264 (73.5) 103 (72.5) 
Rural 94 (26.2) 38 (26.8) 
Missing 1 (0.3) 1 (0.7) 
Current Employment Status (N, %)   
<.0001 
Employed 208 (57.9) 51 (35.9) 
Unemployed/Homemaker/Student/Other 150 (41.8) 91 (64.1) 
Missing/Unknown 1 (0.3) 0 (0.0) 
Number of Adopted or Biological Children Currently 
Living with You (N, %) 
  
0.51 




1 129 (35.9) 46 (32.4) 
2-3 73 (20.3) 33 (23.2) 
4+ 10 (2.8) 7 (4.9) 
Missing/Unknown 2 (0.6) 2 (1.4) 
Private Health Insurance (N, %) 112 (31.2) 33 (23.2) 0.07 
Government Health Insurance (Medicare, Medicaid, 
CHAMPUS, TRI-CARE or other insurance for military 
personnel) (N, %) 
98 (27.3) 49 (34.5) 0.10 
Plan to Use VA Maternity Care Benefits and/or Private 
Insurance for Pregnancy Coverage (N, %) 
  
0.66 
VA maternity care benefits only 279 (77.7) 111 (78.2) 
Private insurance only 8 (2.2) 5 (3.5) 
Both VA maternity care benefits & private 
insurance 
67 (18.7) 24 (16.9) 
Missing/Unknown 2 (0.6) 2 (1.4) 
Other 3 (0.8) 0 (0.0) 
Military Characteristics 
Years of Service (Mean ± SD, Range) 
6.3 ± 3.5 
(1.0-19.0) 
5.8 ± 3.4 
(1.0-22.0) 
0.22 
Deployed (N, %) 235 (65.5) 82 (57.7) 0.06 
OEF/OIF/OND (N, %) 332 (92.5) 132 (93.0) 0.25 
Military Branch (N, %)   
0.78 
Airforce 69 (19.2) 25 (17.6) 
Army 176 (49.0) 75 (52.8) 
Marine Corps 34 (9.5) 17 (12.0) 
Navy 75 (20.9) 24 (16.9) 
Coast guard 4 (1.1) 1 (0.7) 
Civilian employee 1 (0.3) 0 (0.0) 
Component (N, %)   
0.0061 
Active duty 225 (62.7) 108 (76.1) 
National Guard 61 (17.0) 16 (11.3) 
Reserves 71 (19.8) 15 (10.6) 




Service-Connected Disability Status* (N, %) 268 (74.7) 122 (85.9) 0.0009 
Medical and Mental Health History 
Ever received medical treatment for drug abuse or 
alcoholism (N, %) 
21 (5.8) 21 (14.8) 0.0011 
Mental Health Diagnoses (Ever Diagnosed)    
Depression (N, %) 170 (47.4) 116 (81.7) <.0001 
Bipolar Disorder (N, %) 16 (4.5) 16 (11.3) 0.0050 
Other Mood Disorder (N, %) 31 (8.6) 35 (24.6) <.0001 
Anxiety Disorder (N, %) 136 (37.9) 96 (67.6) <.0001 
PTSD (N, %) 118 (32.9) 88 (62.0) <.0001 
Schizophrenia (N, %) 0 (0.0) 1 (0.7) 0.28 
ADHD or ADD (N, %) 23 (6.4) 13 (9.2) 0.28 
Eating Disorder (N, %) 12 (3.3) 10 (7.0) 0.07 
Ever Diagnosis of Any Mental Health Condition** (N, %) 220 (61.3) 130 (91.5) <.0001 
Ever Prescribed Anti-Depressants before Recent 
Pregnancy (N, %) 
168 (46.8) 117 (82.4) <.0001 
Plan to Continue to see Mental Health Provider During 
Pregnancy (N, %)† 
  
<.0001 
Yes, VA Mental Health provider 72 (20.1) 68 (47.9) 
Yes, non-VA Mental Health provider 9 (2.5) 7 (4.9) 
Currently Have a VA Women's Health Provider or VA 
Primary Care Physician (N, %) 
322 (89.7) 123 (86.6) 0.33 
Military Sexual Trauma: Received uninvited and unwanted 
sexual attention while in the military (N, %) 
163 (45.4) 98 (69.0) <.0001 
Military Sexual Trauma: Force or the threat of force was 
used to have unwanted sexual contact while in the military 
(N, %) 
82 (22.8) 68 (47.9) <.0001 
Ever Counseling/Treatment for Military Sexual Trauma 
from VA or non-VA provider (N, %) 
67 (18.7) 55 (38.7) <.0001 
Pregnancy Characteristics 
Weeks Gestation @ Prenatal Interview (Mean ± SD, 
Range) 
23.1 ± 5.2 
(10.4-40.0) 
23.0 ± 5.3 
(4.4-39.1) 
0.87 




Previous Live Birth (N, %) 209 (58.2) 92 (64.8) 0.18 
Previous Miscarriage (N, %) 76 (21.2) 38 (26.8) 0.18 
Previous Abortion (N, %) 15 (4.2) 11 (7.7) 0.10 
Previous Stillbirth (N, %) 8 (2.2) 2 (1.4) 0.73 
Using Contraception at time of Pregnancy (N, %) 36 (10.0) 20 (14.1) 0.19 
Used Fertility Medications or Medical Procedures to get 
Pregnant (N, %) 
34 (9.5) 10 (7.0) 0.39 




8 weeks or less 145 (40.4) 55 (38.7) 
9-12 weeks 161 (44.8) 63 (44.4) 
13 or more weeks 51 (14.2) 24 (16.9) 
Did not receive prenatal care 1 (0.3) 0 (0.0) 
Missing/Unknown 1 (0.3) 0 (0.0) 
Received prenatal care as early as wanted (N, %) 254 (70.8) 93 (65.5) 0.24 
Any Social Support during Pregnancy (N, %) 359 (100.0) 140 (98.6) 0.08 
Seek social support from family member (spouse, partner) 
(N, %) 
340 (94.7) 116 (81.7) <.0001 
Received any VA Maternity Care Coordination Services 
(N, %) 
279 (77.7) 107 (75.4) 0.43 
 
Note: p-values from χ2 tests for categorical variables; for variables with cell sizes <5 Fisher’s Exact p-values are 
reported. P-values for continuous variables from Student’s t-test (with Satterthwaite adjustment when appropriate). 
 
* Service-connected disability status is determined by the Veteran Benefits Administration and measured as a percentage 
from 0% to 100%, where 0% is the lowest level of disability and is different from not having a disability. 
 
**Any mental health condition variable includes self-reported ever diagnosis of any of the following: depression, anxiety, 
PTSD, mood disorder, ADHD/ADD, bipolar disorder, schizophrenia, eating disorder. 
  
†This question was only relevant to participants responding that they had a mental health provider before pregnancy and 




Table 2.2: Results from Multivariable Model* Predicting EPDS ≥10 among Pregnant Veterans in the COMFORT 
Study (n=501) 
 Full Logistic Model Logistic Model with Backward Selection 
 AOR Lower 95% CI 
Upper 





Marital Status (Married vs. Not Married) 0.91 0.52 1.61       
Race (White vs. Non-White) 0.74 0.44 1.25       
Employed vs. Unemployed/Homemaker/Student/Other 0.42 0.25 0.71 0.40 0.24 0.67 
Active Duty vs. National Guard/Reserves/Civilian 1.71 0.95 3.07 1.91 1.08 3.37 
Service-Connected Disability (Yes vs. No) 1.92 0.78 4.72       
Ever Treatment for Drug Abuse or Alcoholism (Yes vs. No) 1.56 0.68 3.59       
Ever Depression Diagnosis (Yes vs. No) 1.41 0.68 2.93       
Ever Bipolar Disorder Diagnosis (Yes vs. No) 0.90 0.35 2.30       
Ever Mood Disorder Diagnosis (Yes vs. No) 1.19 0.58 2.43       
Ever Anxiety Diagnosis (Yes vs. No) 2.14 1.16 3.93 2.54 1.43 4.50 
Ever PTSD Diagnosis (Yes vs. No) 1.10 0.62 1.97       
Ever Antidepressant Prescription Prior to Pregnancy (Yes vs. No) 2.33 1.09 5.00 3.27 1.71 6.24 
Any Military Sexual Trauma** (Yes vs. No) 1.11 0.64 1.94       
Social Support from Spouse/Partner during Pregnancy (Yes vs. No) 0.41 0.18 0.98 0.35 0.16 0.77 
*Hosmer-Lemeshow Goodness of Fit for full logistic model: p=0.8028; for backward selection model: p=0.8338. 
 
**Any military sexual trauma included an affirmative response to any of the following: received uninvited and unwanted sexual attention 
while in the military, force or the threat of force was used to have unwanted sexual contact while in the military, ever counseling/treatment 






CHAPTER III: TREATMENT AND MANAGEMENT OF DEPRESSION 
SYMPTOMS IN PREGNANT VETERANS: VARYING EXPERIENCES OF 




BACKGROUND: Depression screening is recommended for all pregnant veterans; 
however, little is known on how often symptomatic women receive care, how depression 
treatment presents in practice, and whether women veterans are utilizing treatment during 
the perinatal period. 
 
METHODS: Our sample included 142 pregnant veterans from 15 Veterans Health 
Administration (VHA) medical facilities with Edinburgh Postnatal Depression Scale 
(EPDS) scores ≥10. Sociodemographic characteristics, military service, health utilization, 
pregnancy related factors, and qualitative responses to questions regarding mental health 
care during pregnancy were collected as part of a telephone survey.  
 
FINDINGS: A majority of our sample (70%) had 1 or more mental health visits or 
antidepressant prescriptions during pregnancy. Women with a history of depression had 
more mental health visits and a higher percentage of antidepressant use before and during 
pregnancy than women without a history of depression. We identified themes from 
qualitative interviews describing mental health medication risk discussions and use and 
discontinuation of mental health medications during pregnancy. 
 
CONCLUSIONS: Pregnant women veterans without a history of depression may be less 
likely to receive care for depression during pregnancy. However, the majority of our 
veterans showing depression symptoms prenatally had at least one mental health visit or 
an antidepressant medication fill during their pregnancy window, suggesting that mental 
health care is readily available for women veterans. Women veterans described varying 
experiences with medication risk discussions with providers during pregnancy, indicating 






Depression is common during the prenatal period among women veterans.6 
Women veterans are more likely to experience combat-related trauma and post-
deployment stressors, and in general have higher rates of depression, compared to the 
general population.24 A recent prospective study identified depression symptoms in 
nearly 30% of pregnant veterans.53 Despite high rates of depression, there is little 
understanding of how pregnant veterans manage their mental healthcare during 
pregnancy, especially important because the perinatal time marks a distinct period when 
women encounter their providers on a regular basis, offering unique opportunities for 
screening and treatment for depression.54  
Because women remain a numerical minority in the Veterans Health 
Administration (VHA), VHA medical facilities do not provide onsite maternity care. 
Rather, maternity care for veterans is provided by non-VHA obstetricians and reimbursed 
by the VHA. The Department of Veterans Affairs (VA) recommends depression 
screening for all pregnant veterans,4 however, there is a paucity of research regarding the 
frequency or quality of depression treatment during pregnancy. Previous studies suggest 
that while receiving prenatal care from non-VHA providers, a substantial proportion of 
veterans concurrently receive mental health care within the VHA.6,55 Coordination of care 
between non-VHA and VHA providers is an important aspect of maternity care for 
veterans. VA guidelines state that information sharing, “particularly in the area of 
medication management and monitoring for medications that have teratogenic effects,” is 





patient, her mental health provider, and her obstetrician has previously been shown to 
contribute to greater depression treatment during the perinatal period.36,56,57 
Psychotherapy has been shown to be an effective treatment strategy for pregnant 
women with depression.58,59 However, therapy brings its own challenges, among them 
patient barriers such as cost, travel difficulties, and time constraints,59 as well as 
systematic barriers such as lack of provider training, limited access to providers, and 
absence of standardized screening and referral processes.56 
To date, few studies have examined pregnant veterans’ use of antidepressants. 
The prevalence rate of antidepressant use during pregnancy has been estimated to be near 
5% in the general population,60,61 with some point estimates placing antidepressant use at 
any time during pregnancy close to 13%.62 Little is known about the rates of 
antidepressant use among pregnant veterans; however, a previous study reported nearly 
90% of the sample of female veterans of childbearing age had used any prescription 
medication within the past year.63 Antidepressant use during pregnancy is not without 
risk, with associations between antidepressant use and miscarriage, low birthweight, 
preterm birth, and the risk for complications in newborns such as irritability, tachypnea, 
hypoglycemia, and temperature instability in the days following birth.59,64 However, the 
risks of untreated maternal depression include behavior problems and cognitive delays in 
infants, compromised care giving practices, reduced rates of breastfeeding, maternal 
sleep problems, and greater suicidal ideation compared to women without depressive 
symptoms.15,16 Both the VA and the American College of Obstetricians and 





provider regarding continuing or starting an antidepressant medication during 
pregnancy64–66; however, rates as low as 24% have been reported for discussions between 
reproductive age female veterans and their providers about medication risks.63 These 
challenges of available treatment options and the overall low adherence rate to treatment 
among depressed pregnant and postpartum women have yet to be studied among 
veterans36. 
Using a mixed-methods approach, our objective was to evaluate the rate of mental 
health care treatment utilization during pregnancy and to understand the experience and 
management of depression in a sample of pregnant veterans. We identify differences in 
treatment utilization during pregnancy among women who report past diagnoses of 
depression compared to those with no past diagnosis. Additionally, we explore the 
decisions women make regarding antidepressant medication use during pregnancy and 
the extent to which pregnant veterans discuss medication risk counseling with their VHA 
and/or obstetrical providers. 
 
METHODS 
Study Design, Data Source, and Study Sample 
Participants were identified at 15 VHA sites across the US as part of the Center 
for Maternal and Infant Outcomes Research in Translation (COMFORT) study.67 
COMFORT was approved by the Veterans Administration Central Institutional Review 
Board (CIRB) and was given a waiver of consent by the CIRB so that signed consent 





veteran’s VHA provider. To utilize maternity care benefits, women veterans must have a 
visit with their VHA provider to confirm their pregnancies prior to obtaining maternity 
care from an accredited prenatal provider.4 All veterans confirmed to be pregnant were 
mailed recruitment packets that invited the veteran to call a toll-free number to receive 
further information. Additionally, research team members followed up the mailings with 
telephone calls to potential participants. Two telephone surveys were scheduled with 
pregnant veterans who agreed to participate; the first during the second or third trimester 
(around 20-24 weeks of gestation) and a second within three months of delivery.  
 Participants were reimbursed $50 for each survey. Enrollment rates were roughly 
40%; of the 1,410 eligible women who were sent invitation letters, 562 had agreed to 
participate at the time of this analysis. Quantitative study data were collected and 
managed using REDCap (Research Electronic Data Capture), a secure, web-based 
application designed to support data capture for research studies.31 Additionally, 
electronic health record (EHR) data on date of birth, service-connected disability status, 
past medical diagnoses, and healthcare utilization during pregnancy were obtained on 
participants from VA Corporate Data Warehouse (CDW) administrative data. The CDW 
is a repository of data updated nightly from the VHA electronic medical records system 
for operations and research use.32 
Our sample included 142 participants enrolled within the first two years of the 
study (January 28, 2016 – February 6, 2018) and scoring ≥10 on the Edinburgh Postnatal 
Depression Scale (EPDS) administered in the prenatal period; we were able to match 135 





majority (n=5, 71%) did not provide their social security number or only provided the last 
4 digits, preventing identification in the CDW data. The remaining participants (n=2) 
could not be matched with a social security number in the CDW.  
 
Definition of Quantitative Outcomes 
 Healthcare utilization was examined through mental health visits and 
antidepressant use, both as recorded in VHA EHR data and self-reported in the prenatal 
COMFORT survey. We examined healthcare utilization in two time-periods: pre-
pregnancy and pregnancy. We defined pregnancy as 280 days prior to the newborn date 
of birth (available for 59% of our sample) or estimated delivery date (for the remaining 
41% of our sample), as done in previous analyses.40,68 Pre-pregnancy was considered 
prior to the start of the pregnancy time period, defined as 280 to 560 days prior to 
delivery or estimated due date (newborn date of birth-280 days)-280 days) (Figure 3.1). 
This gave us comparable time periods to examine healthcare utilization in our sample 
(i.e., 280 days prior to pregnancy and 280 days during pregnancy).  To identify mental 
health care visits, we utilized VHA mental health stop codes,  indicators in the EHR that 
flag the clinical group responsible for an outpatient encounter (Appendix 3.1).69 We also 
obtained information on receipt of an antidepressant medication, where a 30-day fill 
prescribed at any point during our pre-pregnancy or pregnancy windows was considered 
receipt of a prescription antidepressant. We opted to include only antidepressant 
prescriptions because we specifically asked about antidepressant use in our survey and 





included selective serotonin reuptake inhibitors (SSRI), serotonin–norepinephrine 
reuptake inhibitors (SNRI), tricyclic antidepressants (TCA), monoamine oxidase 
inhibitors (MAOI), noradrenergic and specific serotonergic antidepressants (NASSA), 
norepinephrine-dopamine reuptake inhibitors (NDRI), bupropion, selective serotonin 
reuptake enhancers (SSRE), tianeptine, norepinephrine-dopamine disinhibitors (NDDI), 
and agomelatine (Appendix 3.2). We created a variable, “Any VHA Mental Health Care 
during Pregnancy” defined as one or more mental health visits during pregnancy or any 
receipt of an antidepressant prescription.  
Additionally, we examined self-reported mental health care utilization using 
responses from the prenatal survey. Participants were asked about antidepressant use with 
the following questions: “Before this recent pregnancy, had you ever been prescribed 
anti-depressants?” immediately followed by “Currently, are you taking any medications 
for mental health conditions?”. To identify visits with a mental health provider, 
participants were asked: “At the time you found out you were pregnant were you seeing a 
mental health provider?” and “During this pregnancy will you continue to see a mental 
health provider?”.  
 
Demographic, Military, Health-Related, and Pregnancy Factors 
We selected potential correlates of depression care utilization during pregnancy 
based on previous literature, including history of depression,70 as well as data available 
from the COMFORT telephone survey. The telephone survey collected information 





support, and pregnancy related factors. Participants were asked if they had ever been 
diagnosed with depression. A 10-item Edinburgh Postnatal Depression Scale (EPDS) was 
also administered,30 with a cutoff of 10 used to define present depression symptoms38 and 
a cutoff of 13 used to suggest probable major depression.71 Multiple times during the 
interview, participants were reminded that they could refuse further participation in the 
study or refuse to answer specific questions. Participants with affirmative responses to 
the self-harm question of the EPDS were directed to further clinical follow-up.  
Data used in this analysis included demographics (race/ethnicity, marital status, 
and employment status), military characteristics (deployment history and history of 
military sexual trauma (MST), adapted from the VHA’s universal MST screening 
questions and described in previous literature39), as well as self-reported past mental 
health diagnoses from the COMFORT survey. From the EHR, past depression diagnoses 
were identified as ever being present by the following ICD-9 and ICD-10 diagnosis 
codes: ICD-9: 293.83, 296.2, 296.3, 296.90, 298.0, 300.4, 309.0, 309.1, 311; ICD-10: 
F32, F33, F34, F39. To examine the reliability and validity of self-reported depression 
diagnoses in this sample of veterans, we performed a reliability analysis using 
Cronbach’s α and calculated sensitivity, specificity, and positive predictive values to 
compare to EHR variables for the same diagnoses. We found sensitivity, specificity, and 
positive predictive values rates of 0.90, 0.42, and 0.77, respectively, with most discordant 
cases for women self-reporting the condition when it was absent in the EHR (data not 
shown). Age, OEF/OIF status, and service-connected status were also obtained from 





military tours; service-connected disability status was determined by the Veteran Benefits 
Administration and measured as a percentage from 0% to 100%, where 0% is the lowest 
level of disability and is different from not having a disability1; here dichotomized as 




Prior to the start of recruitment, we developed a semi-structured interview guide 
with questions related to the experiences of veterans regarding depression management 
and other mental health care during pregnancy (Appendix 3.3).  All enrolled veterans 
participated in the semi-structured interview. We selected a purposive sample of 42 
interviews from participants with a prenatal EPDS≥10 in which medication management 
or mental health care were discussed specifically; these interviews were selected from all 
interviews with pregnant veterans showing depressive symptoms. In this mixed methods 
analysis, our quantitative aims informed our qualitative approach through an explanatory 
sequential mixed methods design.72 Our quantitative analyses were prioritized, with 
quantitative data analysis occurring first to inform our qualitative data collection and 
analysis. By doing so, we were able to link our quantitative and qualitative data through 
our sampling frame.72 
The open-ended responses of the interview were digitally recorded to capture 
verbatim content and were professionally transcribed for this analysis. Interview notes 








Descriptive statistics, including means, standard deviations, and ranges for 
continuous variables, and frequencies for categorical variables, were calculated and 
presented.  
To examine correlates of any VHA mental health care during pregnancy, we 
conducted bivariate analyses of variables of interest by our derived mental health care 
variable of one or more mental health visits during pregnancy or any receipt of an 
antidepressant prescription. Chi-squared tests and relative risks with 95% confidence 
intervals were calculated.  
As we additionally sought to learn more about how women veterans treated and 
managed their depression symptoms during pregnancy, we then compared demographic, 
military, and mental health characteristics by women who reported having been 
diagnosed with depression prior to pregnancy versus those who reported no past 
diagnosis. We used chi-squared tests to examine differences in categorical factors and 
Student’s t-test to examine mean differences in continuous factors. 
 We also ran sensitivity analyses to test the reliability of our 280-day pregnancy 
window. We calculated estimated gestational age at delivery in our sample, using the 
difference between the date of the prenatal COMFORT interview and self-reported 
gestational age at that interview to set a “time zero”. We then calculated the difference 





gestational age at delivery was 275.25 days (+/- standard deviation of 10.44) with a 
median and mode of 280 days. Our shortest estimated gestational period was 203 days; 
our longest estimated gestational period was 296 days. Given our minimum and 
maximum estimated gestational window of 203 days and 296 days, respectively, we reran 
our calculations of mental health visits and antidepressant prescriptions for pre-pregnancy 
and pregnancy windows of 200 and 300 days, respectively (Appendices D & E).  
All quantitative analyses were conducted in SAS version 9.2 (SAS Institute, Inc., 
Cary, North Carolina).  
 
Qualitative Analysis 
We utilized a phenomenological approach to understand how pregnant veterans 
managed their depression symptoms and mental health care during pregnancy. 
Phenomenological approaches are used to understand situational experiences viewed 
through the personal perceptions of participants,73,74 requiring the researchers to consider 
the analysis without preconceived ideas or beliefs about the experiences of the 
participants.75 Guided by this approach, we conducted an exploratory, inductive analysis 
similar to methods from previous work.76 This type of analysis is well-suited for our 
semi-structured interview data focusing on pregnancy, where we interpreted participant 
responses through an iterative process.73,74  
We used open coding, where one main coder (ARKD) read participant transcripts 
line-by-line, forming initial notes and definitions and then objectively organized personal 





coder (KM) reviewed these initial codes for clarity and qualitative accuracy. Next, we 
interpreted and refined the experiences shared by pregnant veterans and worked to 
understand the connections between emergent themes and their descriptions of how these 
experiences are shaped, using our explanatory sequential approach to support our 
quantitative findings and/or add new perspectives that were not garnered from our 
quantitative survey.72 Findings were organized by clusters of superordinate and 
subthemes in a coherent order, retranslated into a narrative account, and considered in 
relation to quantitative results. Qualitative analysis was managed in ATLAS.ti version 




Women in our sample were on average 31.4 years of age (+/- 4.5), married 
(50.7%), white (52.1%), and deployed in the past (57.7%). Prenatal EPDS scores 
averaged 14.7 (+/- 4.0) (Table 3.1). Overall, the number of mental health visits increased 
slightly from the pre-pregnancy to pregnancy time periods, from 5.3 visits in the 280 days 
prior to pregnancy, to 6.1 visits during the 280-day pregnancy window (Wilcoxon signed-
rank test p=0.18). Antidepressant use decreased from 40.1% in pre-pregnancy to 37.0% 
of our sample having received a similar prescription during pregnancy (McNemar's test 
for paired samples p=0.21).  
A majority of our sample (69.7%) had at least 1 mental health visit or 





sexual trauma (MST) (χ2 p=0.002) and drug abuse or alcoholism (χ2 p=0.004), self-
reported diagnosis of depression (χ2 p=0.0002), PTSD (χ2 p=0.002), mood disorder (χ2 
p=0.009), and bipolar disorder (Fisher’s Exact Test p=0.02), past use of antidepressants 
(χ2 p<.0001), and established care with a VHA mental health provider prior to pregnancy 
(χ2 p<.0001) were significantly associated with at least 1 mental health visit or 
antidepressant prescription during pregnancy. Employment was associated with a 
decreased likelihood of a mental health visit or antidepressant prescription during 
pregnancy (χ2 p=0.03) (Table 3.2).  
A large proportion of our sample (81.7%) reported a past diagnosis of depression. 
Those reporting a history of depression were statistically more likely to score a prenatal 
EPDS≥13, suggestive of major depressive symptoms (68% vs. 42%, p=0.01). Women 
reporting no history of depression were more likely to be employed (54% vs. 32%, 
p=0.04), less likely to report treatment for military sexual trauma (19% vs. 43%, p=0.02), 
and less likely to report past diagnoses of PTSD, and bipolar, mood, and anxiety 
disorders (all p<0.05) (Table 3.3).  
Care utilization was higher in women with a self-reported history of depression, 
with a greater number of mental health visits before and during pregnancy and a higher 
percentage of antidepressant use during these same time periods, with 75.9% of women 
with a history of depression having some VHA mental health care during pregnancy, 
compared to only 42.3% of women with no history of depression (p<0.001) (Table 3.2; 
Figures 3.2 & 3.3). This corresponded to women with a self-reported history of 





antidepressant prescription during pregnancy than women without a history of depression 
(data not shown; relative risk=1.8, 95% confidence interval=1.1-2.8).  
Our sensitivity results indicated that the proportion of our sample with CDW data 
(n=135) who had mental health visits and/or antidepressant prescriptions varied 
depending on the pregnancy window we used (200-days, 280-days, or 300-days). The 
number of mental health visits increased as time windows were broadened. Receipt of an 
antidepressant prescription was present in 21.5% of women when examining a 200-day 
pregnancy window; when that window was expanded to 280-days and 300-days, 37% 
and 40% of women had received an antidepressant prescription, respectively. Women 
receiving at least one VHA mental health visit or antidepressant prescription increased 
slightly when comparing our 200- and 280-day windows (63.7% vs. 73.3%) but remained 




We identified themes that captured the major concepts surrounding medication 
use during pregnancy, including themes relevant to mental health medication risk 
discussions with providers, use of mental health medications during pregnancy, and 
discontinuation of mental health medications during pregnancy (Table 3.4).  
 
 “Once I knew, I stopped.” Many women reported discontinuing their 





knew, I stopped taking everything…I just went off, completely off of everything, 
everything.”  One woman who had a planned pregnancy noted that she was trying to “do 
better as far as managing (her depression)” to “prevent” her from going back on 
medication while pregnant. Another woman stated that she “kind of quit taking” her 
antidepressants, but later informed her mental health provider and came up with 
alternative treatment plans. 
Most participants indicated they made the decision to stop on their own. A 
number of participants reported not feeling comfortable with medication in general (“I’m 
not a huge believer in long term medicated management for mental health”), and even 
more so during pregnancy. Very few women in our sample expressed awareness of the 
risks of abruptly discontinuing their medications, although one participant did share her 
fears about the potential risks of being on medication and then subsequently weaning 
herself off too quickly. 
 
A Coordinated Decision. Because the COMFORT prenatal interview took place 
following the participant’s visit with her VHA provider for pregnancy confirmation, an 
opportunity for medication review and risk discussion existed. While many participants 
reported such discussions with their VHA providers or their obstetricians, collaboration 
between VHA providers and obstetricians was minimally reported and most participants 
were unsure whether information about mental health status was being transmitted 
between their VHA and obstetric providers. Those who spoke about coordinated 





consensus on a treatment plan during pregnancy. One participant spoke about her mental 
health provider collaborating with her obstetrician to the extent of changing a medication 
so that both providers and the patient were comfortable with the treatment:  
"The VA had done a great job of providing peer reviewed information saying their 
decision about why they think that certain medications are safe during pregnancy. 
And when that, I think professional opinion, didn’t align with what the OBGYN 
thought they were very happy to basically concede and change the prescription.”  
 
Another woman expressed satisfaction with the coordinated decision between her VHA 
provider and obstetrician to have her remain on her medication during pregnancy:  
“She (VA nurse practitioner) was wonderful, she actually looked up the 
medications because she knew that I had gotten on the medications before I was 
breastfeeding. So we were very careful about getting on it and I was postpartum 
from my prior pregnancy, because I had back to back pregnancies they (VA NP 
and OB) both agreed about keeping me on the medication. She (VA NP) asked me 
to make sure that my OB was on the same page. And he already was so she was 
more than helpful. She actually went above and beyond.”  
 
However, many participants reported not having a discussion with either their 
VHA mental health providers or their obstetricians, or having a discussion but remaining 
confused about potential risks during pregnancy. As one woman said: 
"I think it was kind of a mutual decision, I had her tell me all of the risks and she 
went over all, you know, the different studies or whatever that she had pulled up 
and it just… I just thought (medication) sounded dangerous and it passed through 
milk and things like that, so I said I definitely wanted to get off (of) that.” 
 
Another woman shared that her VHA primary care provider was not helpful when 
she asked about a mental health medication she was taking, and that she had done her 





“I did my research online as far as all that went, like I said, when I (tried) to talk 




Not Worth the Risk. Few women reported use of mental health medications during 
pregnancy. Women who were hesitant to start or restart a medication explained that 
potential risks to the fetus influenced their decision. Women spoke about medication 
being “very dangerous” and risky even if their providers suggested a prescription and 
assured them the risks were minimal. One participant said, “I read all the manufacturing 
and the risks and everything and some of them said don’t take while you’re pregnant and 
so I didn’t want to have any risks associated with it.”  Another participant commented, “I 
just don’t take them. I stopped taking them, just because I didn’t want any developmental 
issues or whatever with the baby.” Additionally, one woman added: 
“Yeah, she’s (provider) even mentioned like taking some antidepressants, but I 
told her, you know, I’m not a big person on medicine as it is, so I don’t like to 
take medicine, especially like when I’m pregnant…You know because I just don’t 
want to take the risk.” 
 
One participant discussed stopping due to past experiences:  
“Well, I was taking (medications) for mental health before I got pregnant, then I 
stopped when I found out I was pregnant cause I don’t know, you know, how 
would that affect the pregnancy, cause I already had two previous miscarriages 
before this baby.” 
 
Justifying Treatment. Women who spoke about taking medications during 
pregnancy seemed to include reasons for justifying their use. One woman spoke about her 





“(My emotions) were either really sad, tired, angry; where I either wanted to sit 
in bed all day or sit in the shower and cry all day, or if I was angry, I mean it was 
to the verge of wanting to hurt others. So my OBGYN she put me (on) the generic 
brand of Zoloft…it’s helped drastically…I wasn’t on any medications whatsoever 
until I got pregnant.”   
 
Another woman who discontinued her medication during the first trimester but restarted 
later in pregnancy noted potential changes to her hormones as being the cause for 
returning symptoms: 
“I stopped taking my fluoxetine when I found out I was pregnant. And I was, it 
was after I was twelve weeks that I started taking it again. I’m not sure the exact 
week but I remember the doctor said that after twelve weeks it would probably be 
okay for me to start taking it again. So things got a little bit rough…I don’t know 
if it was the hormones that were a little more crazy but it definitely wasn’t very 
good.”  
 
Difficulties Adjusting to Life without Medication. Many women reported 
difficulties adjusting to life without medications to manage their depression. As one 
woman put it, she had to accept that her depression “is going to be an occasional problem 
until after I have the kid.” Others expressed that techniques to help manage depression 
were not as effective during pregnancy, or that traveling to mental health appointments 
had become more difficult since becoming pregnant. One woman said that although she 
was grateful for the techniques she learned in therapy, without medication “it’s just 
tough, it’s really tough to manage that and just, you know, go almost a year without 
having any medication for it.” Very few women discussed starting therapy or utilizing 
other forms of treatment in place of antidepressants. One woman shared her hesitation 





“Well, to be honest, all the things I’ve been through since I’ve been pregnant (has 
been with) my OBGYN…I haven’t really spoke with my (VA) primary care 
provider or I haven’t spoke with the therapist there…I don’t know, like, and I 
know this might sound crazy, but it’s like I don’t feel too comfortable, I guess, 




To our knowledge, this is the first study to examine mental health care and 
depression treatment during pregnancy in veterans with depression symptomatology. 
More than half of our sample had at least one mental health visit at the VHA or received 
a prescription for an antidepressant in the 280-days prior to delivery thus corresponding 
with the pregnancy period. However, nearly a quarter of our sample did not receive any 
VHA mental health care during their pregnancy. The majority of our participants (82%) 
reported using antidepressants at any time prior to their pregnancies, yet only 35% our 
sample filled a prescription for an antidepressant in the 280-days prior to delivery. We 
expected a large proportion of our sample would discontinue use because past research 
suggests women taking antidepressants prior to pregnancy discontinue use in the prenatal 
period.77 Given that treatment for depression will likely decrease further following the 
birth of the child when time and childcare become barriers to treatment,56 that medication 
recommendations change over the perinatal period, and that over half of perinatal 
depression cases develop prior to the postpartum period,11 identifying at-risk and 
symptomatic women during pregnancy is key to developing a practical treatment routine.  
We found that women self-reporting a history of depression were more likely to 





women veterans without a pre-pregnancy mental health diagnosis were less likely to seek 
outpatient mental healthcare during their pregnancies compared to women veterans with 
a pre-pregnancy mental health diagnosis.43 Most women who received care in the pre-
pregnancy period remained in care during pregnancy; however, women without past 
diagnoses may potentially be overlooked if depression screening is not done on a routine 
basis. The women veterans in our analysis who did not report a history of a depression 
diagnosis comprised 5% of all pregnant veterans in our sample with a prenatal EPDS≥10, 
suggestive of depression symptomatology.53  
The frequency of care utilization among women veterans in our sample differed 
considerably between women with a self-reported history of depression compared to 
those with no self-reported history of depression. The VA Maternity Health Care and 
Coordination Handbook defines a standard of practice for maternity care coordination 
within VHA medical facilities, instituted to bridge the gap between existing dual 
VHA/non-VHA healthcare systems and designed to "ensure that eligible women 
Veterans have access to timely prenatal care…(and) seamless coordination of non-VA 
maternity care with VA care, especially in cases of women Veterans with co-morbid 
conditions who may require VA care during their pregnancy."4 These guidelines also 
recommend depression assessment, screening, counseling, and referral for care as 
components of the coordination model. The guidelines specify that "VA providers must 
screen all pregnant and postpartum women for depression utilizing an appropriate 
screening tool, and have a system to ensure that positive screening results are followed by 





or through referral."4 Given our quantitative findings showing that women without a 
history of depression were less likely to utilize care during pregnancy, conducting early 
and frequent depression screening, as well as establishing referral processes and 
introducing women without a history of mental health care to the mental health resources 
at the VHA is key for this population. Our results indicate that veterans experiencing 
depression symptoms may be lacking access to treatment, despite guidelines encouraging 
systems to identify these women and establish a care routine. 
Veterans in our sample qualitatively reported varying experiences with mental 
health care treatment during pregnancy. While many women reported discontinuing 
medications after discussions of associated risks with providers, several women reported 
discontinuing medications on their own, without a risk/benefit discussion with their 
providers. This is consistent with other work showing that, in general, women tend to 
make a decision to discontinue medications during pregnancy without the benefit of a full 
discussion with their providers.78 A lack of discussion between patients and providers 
may also be suggestive of reluctance that provider’s may have with discussing and 
prescribing antidepressant during pregnancy,57,79 despite patients preferring their 
providers initiate the discussion about medication risks during pregnancy.80 Additionally, 
as has been reported in similar studies, the fear of harming the fetus often results in 
medication discontinuation during pregnancy.81,82 The stigma surrounding medication use 
during pregnancy is pervasive. Previous work has found pregnant women expressing 
difficulties in accepting the need for a medication during pregnancy78 given the prevalent 





recognition of the risks of untreated mental health conditions being associated with 
significant risk for mother and child. Our sensitivity analyses showed a greater number of 
antidepressant prescriptions in the 280-day and 300-day windows compared to the 200-
day window when looking back from the date of delivery or estimated due date; this may 
be quantitative evidence that many women are discontinuing their antidepressant 
prescriptions early in pregnancy.  
Our study is not without limitations. It is possible that women started taking an 
antidepressant or seeing a mental health provider following the prenatal interview, which 
ranged from 4-39 weeks gestation in our sample, and thus would not be captured in the 
self-report responses. Outside of the prenatal interview question specifically asking about 
antidepressant use prior to pregnancy, our interview included broad questions regarding 
self-reported receipt of mental health care rather than solely focusing on depression. 
Additionally, we may have included antidepressant prescriptions or mental health visits 
from the CDW data outside the actual pregnancy window, such as prescriptions filled in 
very early pregnancy which may have been stopped upon pregnancy confirmation. 
However, our sensitivity analyses using varying pregnancy windows of 200 and 300 days 
showed expected differences of increases in mental health visits and decreases in 
antidepressant prescriptions when our pregnancy time was varied. Likewise, we were 
unable to identify mental health care received during pregnancy from a non-VHA 
provider, which may explain our low specificity calculations. Given that most discordant 
cases were due to women self-reporting depression where it was shown absent in the 





veteran was receiving VHA care or made by a provider outside of the VHA system). We 
also only included antidepressant prescriptions in our analysis. We chose to focus on 
depression symptomology for this paper; however, this potentially excludes a wide range 
of other mental health medications our participants may have been taking. Finally, our 
findings are not generalizable to a population outside of English-speaking pregnant 
veterans receiving their care within the VHA medical system. 
Our study also has several strengths. We enriched our survey dataset with EHR 
data and examined the sensitivity and specificity of our participants self-reported history 
of depression diagnoses compared to EHR records. We used both quantitative and 
qualitative data to enrich our understanding of mental health care of pregnant veterans. 
We utilized a large, national sample to enroll participants. Additionally, we used the 
EPDS which has been validated as a screening tool for use in a pregnant population.38 
Finally, our qualitative data was obtained from semi-structured interviews, which gave 
the participants flexibility in their responses.  
 
CONCLUSIONS 
Estimates of depression prior to pregnancy in women veterans range from 10-
60%, suggesting a higher likelihood of pregnant veterans developing depression 
compared to pregnant women in the general population,6,19 and depression is the most 
commonly diagnosed medical condition among all women veterans ages 18-44.22 The US 
Preventive Services Task Force (USPSTF) recently issued a draft recommendation that 
clinicians “provide or refer pregnant and postpartum women who are at increased risk of 





lack of current guidelines for preventing perinatal depression, in light of evidence 
showing that counseling interventions can help improve perinatal depression outcomes. 
The USPSTF recommends identifying women at-risk for perinatal depression early, 
based on risk factors such as a history of depression, current depressive symptoms, and 
socioeconomic risk factors. Women veterans, especially given their increased risk of 
depression, could benefit from preventative therapy and other interventions targeting 
awareness around the importance of treating depression during pregnancy. These 
discussions should include non-pharmacologic and pharmacologic treatment options 
including balanced risk discussion addressing outcomes associated with untreated and 
treated disease. Our study reveals that treatment and care experiences vary among women 
veterans substantially. Women veterans without a history of depression may be less likely 
to receive care for depression symptoms during pregnancy. However, a majority of our 
sample with prenatal depression symptoms had at least one mental health visit or an anti-
depression medication fill during their pregnancy window, suggesting that mental health 
care is available for women veterans when accessed.  
 
IMPLICATIONS FOR PRACTICE AND/OR POLICY 
Further work needs to be done to understand the extent of depression screening, 
medication adherence, and treatment options among veterans in the perinatal period, 
especially for pregnant women with new onset symptoms who may not have had a 
previous encounter with VHA mental health. Consistency in care, such as therapy for 





discussions, could help veterans and providers better manage depression during 





TABLES & FIGURES 
 
Figure 3.1: Time Periods of Mental Health Care/Antidepressant Prescription 







Table 3.1: Participant Characteristics (n=142) 
COMFORT Survey Data 
 Total 
Age at Prenatal Interview (Mean ± SD, Range) 
31.4 ± 4.5 
(22.4-41.7) 
Married (N, %) 72 (50.7) 
Race: White (N, %) 74 (52.1) 
Hispanic or Latino/Latina (N, %) 22 (15.5) 
Past Deployment (N, %) 82 (57.7) 
OEF/OIF (N, %) 134 (94.4) 
Prenatal EPDS (Mean ± SD, Range) 14.7 ± 4.0 (10.0-26.0) 
Symptoms of Probable Major Depression, EPDS≥13 (N, %) 90 (63.4) 
Weeks Pregnant at Prenatal Interview (Mean ± SD, Range) 
23.0 ± 5.3 
(4.4-39.1) 
Care Utilization from VA CDW Electronic Health Record* 
Mental Health visits, mean +/- SD (range)  
Pre-pregnancy  5.3 +/- 9.1 (0-45) 
Pregnancy 6.1 +/- 9.4 (0-54) 
Any Mental Health visits, n (%)  
Pre-pregnancy  79 (55.6) 
Pregnancy  91 (64.1) 
Antidepressant Prescription, n (%)  
Pre-pregnancy  57 (40.1) 
Pregnancy  50 (35.2) 
Any VHA Mental Health Care during Pregnancy (1+ mental health 
visit or antidepressant prescription in VA CDW EHR) (N, %) 
99 (69.7) 
Abbreviations: CDW: Corporate Data Warehouse; EPDS: Edinburgh Postnatal Depression Scale; 
OEF/OIF: Operation Enduring Freedom/Operation Iraqi Freedom; VA: Veterans Affairs; VHA: Veterans 
Health Administration 
 
Note: Time periods calculated as Pre-pregnancy=(Newborn date of birth-280)-280; Pregnancy=Newborn 
date of birth-280 
 







Table 3.2: Factors Significantly Associated with Any VHA Mental Health Care during Pregnancy* (n=135) 





Employed vs. Unemployed/Homemaker/Student/Other 4.99, 0.03 0.41 0.19 0.91 
Treatment for Military Sexual Trauma (Yes vs. No) 9.90, 0.002 4.34 1.66 11.35 
Ever Treatment for Drug Abuse or Alcoholism (Yes vs. No) 8.54, 0.004 - - - 
Ever Depression Diagnosis (Yes vs. No) 13.50, 0.0002 5.09 2.03 12.74 
Ever PTSD Diagnosis (Yes vs. No) 9.83, 0.002 3.45 1.56 7.62 
Ever Mood Disorder Diagnosis (Yes vs. No) 6.90, 0.009 4.78 1.36 16.81 
Ever Bipolar Disorder Diagnosis (Yes vs. No) 5.68, 0.01** - - - 
Ever Antidepressant Prescription Prior to Pregnancy (Yes vs. No) 17.43, <.0001 6.36 2.51 16.12 
Plan to See VHA MH Provider during Pregnancy (Yes vs. No) 34.43, <.0001 35.44 7.44 168.73 
 
*1+ mental health visit or antidepressant prescription in VA CDW EHR. 
**Fisher’s Exact Test for small cell sizes. 
***No risk estimate computed for Ever Treatment for Drug Abuse or Alcoholism or Ever Bipolar Disorder Diagnosis due to no self-report of either past 
condition in the “no VHA care during pregnancy” group. 







Table 3.3: Participant Characteristics by Self-Reported Past Depression Diagnosis 
(n=142) 
Characteristic 






Probable Symptoms of MDD (Prenatal EPDS ≥13) (N, %) 11 (42.3) 79 (68.1) 0.01 
First Pregnancy (N, %) 10 (38.5) 32 (27.6) 0.27 
Current Employment Status (N, %)    
Employed 14 (53.8) 37 (31.9) 
0.04 
Unemployed/Homemaker/Student/Other 12 (46.2) 79 (68.1) 
Service-Connected Status (N, %) 22 (84.6) 103 (88.8) 0.39* 
Ever Counseling/Treatment for Military Sexual Trauma (N, %) 5 (19.2) 50 (43.1) 0.02 
Ever received medical treatment for drug abuse or alcoholism 
(N, %) 
1 (3.8) 20 (17.2) 0.12* 
Self-Reported Mental Health Diagnoses, Ever Diagnosed (N, %)    
Bipolar Disorder  0 (0.0) 16 (13.8) 0.04* 
Other Mood Disorder  0 (0.0) 35 (30.2) 0.001 
Anxiety Disorder  8 (30.8) 88 (75.9) <.0001 
PTSD  9 (34.6) 79 (68.1) 0.002 
Schizophrenia  0 (0.0) 1 (0.9) 0.99 
ADHD or ADD  0 (0.0) 13 (11.2) 0.13* 
Eating Disorder  0 (0.0) 10 (8.6) 0.21* 
Self-Reported Ever Diagnosis of Any Mental Health 
Condition** (N, %) 
14 (53.8) 116 (100.0) <.0001* 
Self-Reported Ever Diagnosis of Any Mental Health 
Condition**, excluding depression (N, %) 
14 (53.8) 94 (81.0) 0.003 
Care Utilization 
Seeing MH provider when found out about pregnancy, self-
reported (N, %) 
7 (26.9) 62 (53.4) 0.03 
Planned to see MH provider during pregnancy, self-reported (N, 
%) 
7 (26.9) 68 (58.6) 0.36 












Any VHA Mental Health Visits during 280-Day Pregnancy 
Window (N, %) 
11 (42.3) 80 (69.0) 0.006 
VHA Mental Health Visits during 280-Day Pregnancy Window 
(Mean ± SD, Range) 
2.7 ± 4.7 
(0-18) 
6.9 ± 10.1 
(0-54) 
0.003* 
Ever Prescribed Anti-Depressants, self-reported (N, %) 10 (38.5) 107 (92.2) <.0001* 
Mental health medication use at the time of prenatal interview, 
self-reported (N, %) 
0 (0.0) 22 (19.0) 0.02* 
VHA Antidepressant Prescription Pre-pregnancy (N, %)  6 (23.1) 51 (44.0) 0.04 
VHA Antidepressant Prescription during 280-Day Pregnancy 
Window (N, %) 
3 (11.5) 47 (40.5) 0.004 
Any VHA Mental Health Care during Pregnancy (1+ mental 
health visit or antidepressant prescription in VA CDW EHR) (N, 
%) 
11 (42.3) 88 (75.9) 0.0002 
 
*P-value from Fisher’s exact test for categorical variables; Satterthwaite test for unequal variances for continuous variables. 
**Any mental health condition variable includes self-reported ever diagnosis of any of the following: depression, anxiety, 
PTSD, mood disorder, ADHD/ADD, bipolar disorder, schizophrenia, eating disorder. 
 
Time periods: Pre-pregnancy=(Newborn date of birth-280)-280; Pregnancy=Newborn date of birth-280 
 





Figure 3.2: Mental Health Treatment Utilization*, by Pregnancy Period and Self-Reported Past Depression Diagnosis 
(n=135) 
 
*Mental Health Treatment Utilization: 1+ mental health visit or 30-day antidepressant prescription in VA Corporate Data Warehouse Electronic 
Health Record Data. Note: 7 of our participants (n=1 with no past depression; n=6 with past depression) did not have CDW data; therefore this 
































Figure 3.3: VHA Mental Health Visits* Recorded in the 280 Days Prior to Delivery, 
by Self-Reported Past Depression Diagnosis, among Pregnant Veterans with 
Depression Symptoms (n=135) 
 
*As recorded in the VA Corporate Data Warehouse Electronic Health Record Data 
Note: 7 of our participants (n=1 with no past depression; n=6 with past depression) did not have CDW 









Table 3.4: Categories, Example Codes, and Themes Identified from Qualitative Interviews with Pregnant Veterans 
with Depression Symptoms (n=42) 
Category Example Codes Themes 
Medication Risk Discussion 
with Providers 
• Communication between obstetrician and VHA provider 
• Occurred with obstetrician 
• Occurred with VHA provider 
• Personal understanding of risks 
A Coordinated Decision 
Use of Medications during 
Pregnancy 
• Continued medication use 
• New medication use Justifying Treatment 
Discontinuation of 
Medications during Pregnancy 
• Alternative treatments 
• Feelings about stopping 
• Personal decision 
• Provider Decision 
“Once I knew, I stopped” 
 
Not Worth the Risk 
 








CHAPTER IV: BRIDGING THE GAP FOR PERINATAL VETERANS: CARE BY 





BACKGROUND: Pregnant women veterans receive maternity care from community 
obstetricians but continue to receive mental health care within the Veterans Health 
Administration (VHA). Our objective was to explore the experiences of VHA mental 
health providers with pregnant and postpartum veterans. 
  
METHODS: Mental health providers (n=33) were identified at 14 VHA facilities across 
the US. Semi-structured interviews were conducted over the phone to learn about 
provider experiences with perinatal women veterans and their perceptions of depression 
screening and mental health treatment management for pregnant and postpartum veterans 
receiving mental health care within the VHA system. 
 
FINDINGS: Providers identified absence of screening protocols and referral procedures 
and variability in risk/benefit conversations surrounding psychotropic medication use as 
important areas of weakness for VHA mental health care during the perinatal period. 
Care coordination within facilities, primarily through Primary Care-Mental Health 
Integration teams, was identified as a main facilitator to promoting better mental health 
care for perinatal veterans. 
 
CONCLUSIONS: Mental health providers caring for veterans during the perinatal 
period identified several areas where care could be improved, notably in screening and 
referral processes. Given the presence of strong internal care coordination examples 
already in place at many VHA facilities, improving access to mental health care for 






The number of reproductive-aged women veterans utilizing Veterans Health 
Administration (VHA) benefits to pay for maternity care is increasing.3 Because few 
VHA hospitals provide prenatal care, nearly all maternity care for veterans is provided by 
external obstetrical providers through the Veterans Affairs (VA) Community Care 
program, which pays for prenatal and maternity care coverage at community-based 
obstetrical providers.3–5 However, veterans often continue to receive mental health care 
from VHA mental health providers during the perinatal period, which encompasses 
pregnancy and the first postpartum year.6,86 It remains unclear on how women veterans 
navigate their pregnancy and postpartum mental health care and whether they are 
receiving adequate screening for perinatal depression. 
 In an effort to ensure pregnant women have access to community-based 
obstetrical care while continuing to receive ongoing VHA care as needed, the VHA 
issued maternity health care and coordination procedures with VHA Handbook 1330.03. 
The guidelines are designed to bridge the gap between the existing dual VHA/community 
healthcare systems and to "ensure that eligible women Veterans have access to timely 
prenatal care…(and) seamless coordination of non-VA maternity care with VA care, 
especially in cases of women Veterans with co-morbid conditions who may require VA 
care during their pregnancy."4 This includes coordination of “non-VA maternity care 
with relevant VA providers” as well as coordination between internal VA providers. A 
model for this internal VHA provider coordination is Primary-Care Mental Health 




primary care and mental health providers; they were established to promote collaboration 
between disciplines to promote the effective treatment of common mental health 
disorders, including depression.87 PC-MHI models have been previously associated with 
greater identification of mental health diagnoses.88 PC-MHI models are utilized for all 
veterans, but provide a framework for the specific care of pregnant and postpartum 
veterans. 
 Depression screening, assessment/diagnosis, and treatment, including counseling 
and referrals to care, are included as components of the maternity health care guidelines, 
and are necessary to proceed through on the depression care pathway to improve 
symptomatology and maternal/child outcomes. VHA Handbook 1330.03 specifies that 
"VA providers must screen all pregnant and postpartum women for depression utilizing 
an appropriate screening tool, and have a system to ensure that positive screening results 
are followed by accurate diagnosis, implementation of treatment, and follow-up either 
within the practice or through referral."4 The VA/DoD Clinical Practice Guideline for the 
Management of Pregnancy is referenced for further details on specific screening tools and 
referral processes. Depression screenings in the VA/DoD guidelines are recommended to 
be conducted “using a standardized tool such as the Edinburgh Postnatal Depression 
Scale or the 9-item Patient Health Questionnaire periodically during pregnancy and 
postpartum,” with periodic screening defined as once each in the first trimester, third 
trimester, and postpartum.29 
Studies have shown that screening for depression is enough of an intervention to 




and in general, that perinatal depression screening is acceptable to patients.89 VA clinical 
care guidelines recommend depression screening at the initial preventative medicine visit, 
a visit required by the VHA to confirm pregnancy and initiate maternity care benefits.4 
However, mental health providers are not involved in this screening and it is unknown if 
they receive referrals through the initial visits when this screening may take place. 
Additionally, as the onset of perinatal depression can occur at various times over the 
course of pregnancy and the year postpartum,11 screening for depression at multiple times 
in the perinatal period is important to facilitate early engagement with mental health care. 
Because women veterans with depression may find it burdensome to seek care in a 
complex dual healthcare system during pregnancy,90 a proactive approach to contacting 
veterans for screening may be needed. 
Our objective was to explore the experiences of VHA mental health providers 
with pregnant and postpartum veterans as well as their perceptions regarding depression 
screening and mental health treatment management during the perinatal period. We used 
semi-structured interviews with mental health providers from VHA facilities across the 
US to better understand typical mental health care and treatment experiences and to 
explore instances of care coordination occurring at their facility.  
 
METHODS 
Mental health providers (including psychologists, social workers, and 
psychiatrists) were identified from facilities participating in a larger cohort study, the 




recruited pregnant veterans from VHA facilities across the US. Our sample was 
purposively selected, with the goal to interview at least one, but ideally two or more, 
providers from each of the 14 COMFORT study facilities. The lead facility investigator 
for the COMFORT study provided contact information for mental health providers with 
experience working with pregnant and postpartum veterans at their respective facility. 
Additionally, several providers were referred to COMFORT research staff directly by 
other study participants. After receiving contact information, COMFORT research staff 
contacted providers via email to provide information about the study and the topics to be 
covered, and to schedule interviews. The interview guide utilized for the study (Appendix 
4.1) was developed by COMFORT investigators and refined after pilot interviews. 
Interviews took place between August 2017 and February 2018. 
Semi-structured interviews were conducted over the phone at a time that was 
agreeable for the mental health provider. Semi-structured interviews allowed for greater 
spontaneity for the providers to discuss their thoughts and experiences working with 
pregnant and postpartum veterans. After describing the study and receiving verbal 
consent from the mental health provider to have the conversation recorded, interviews 
started with "grand tour" questions to orient the mental health provider to the topic, such 
as: “Could you tell me more about your current job responsibilities?” and “How often do 
you work with women before, during, or after pregnancy?” These opening questions were 
followed by probes to learn more specific details of the mental health provider’s 
experiences with perinatal women veterans. Demographic and occupation characteristics 




Interviews lasted around 30 minutes. They were digitally recorded to capture 
verbatim content, and professionally transcribed. All data were stored on a secure 
password-protected VHA server. Recordings were destroyed upon verification and 
confirmation of complete interview notes. COMFORT was approved by the Veterans 
Administration Central Institutional Review Board (CIRB). Only study staff with CIRB 
approval could access the transcripts and audio data. 
 
ANALYSIS 
We used a conventional content analysis to identify initial coding categories 
directly from the interview data.91 Each transcript was read by a primary coder (ARKD) 
to identify emergent themes. Findings were organized by clusters of superordinate and 
subthemes in a coherent order and retranslated into a narrative account. A second coder 
(KM) reviewed themes for qualitative accuracy. A final coding structure, consisting of 49 
codes, captured the major concepts in the data. The themes included in the present 
analysis emerged from codes describing the use and discontinuation of mental health 
medications during pregnancy, risk discussions surrounding mental health medication use 
during pregnancy and postpartum, depression screening and protocol adaptation, and care 
coordination, all within the context of the guidelines in VHA Handbook 1330.03.  
Qualitative analysis was managed in ATLAS.ti version 8.2.30 (Scientific 







We conducted a total of 31 interviews with 33 providers. Two of our interviews 
took place with two providers from the same facilities simultaneously. One provider did 
not want her interview recorded. Therefore, our analysis included 30 transcripts. Of the 
54 total providers contacted, 45 were eligible for an interview. Our overall participation 
rate was 73%. Of those providers who did not participate in an interview, the most 
common reason was non-response to invitation emails (67%) (Figure 4.1). Interviewed 
providers were predominately female (97%) and white (82%) and were on average 45 
years old with 10 years of VHA work experience (Table 4.1). At least one provider was 
interviewed from each of the 14 COMFORT facilities; most facilities (87%) had two to 
four providers participating in interviews. Providers mainly included psychologists, 
psychiatrists, and physicians (73%) (Table 4.2). Our sample included both prescribers 
and non-prescribers. Prescribers included any provider, such as psychiatrists, physicians, 
and nurse practitioners, able to prescribe antidepressants and other medications. Non-
prescribers included Licensed Clinical Social Workers and others who provide 
counseling but not prescription medications to their patients. Providers reported varying 
frequency in working with pregnant and/or postpartum veterans, with some seeing 
perinatal veterans often and others treating only a handful of perinatal veterans 






Providers spent a substantial amount of time discussing care coordination, general 
care experiences, and usual treatment experiences with perinatal patients (Table 4.3). 
Absence of screening protocols, referral procedures, and variability in risk/benefit 
conversations surrounding psychotropic medication use were identified as important 
areas of weakness for VHA mental health care during the perinatal period. Primary Care-
Mental Health Integration teams were identified as a main facilitator to promoting better 
mental health care for perinatal veterans. From our final coding categories we identified 
the following themes: Wide Variation in Screening of Pregnant Women Across Facilities, 
Inconsistencies in Treatment Decision-Making, Lack of Communication with 
Obstetricians, and Coordination through PC-MHI Teams. Below we outline these 
findings, grouped by thematic category.  
 
Wide Variation in Screening of Pregnant Women Across Facilities   
Many providers expressed concern that depression screening, diagnosis, and 
treatment were occurring too infrequently, and thus were concerned about missing 
opportunities for women to get care. Providers reported frequent contact with women 
they had been seeing prior to pregnancy but only a few new onset depression cases. One 
provider acknowledged that new onset cases of depression in perinatal veterans, “may 
definitely be slipping through the cracks.” Another provider expressed her concern that 
screening was not done frequently enough to identify depression, especially for women 
who may not be aware of depression symptoms or risk factors:  
“I mean I think we know that there’s probably underdiagnosed (and) 




wonderful life event that just happened and so I think it can be hard to 
acknowledge that ‘yeah I’m sometimes feeling kind of down and/or having 
difficulty’, so I think if we more routinely did it (screened for depression) we 
would probably catch some cases we’re not aware of right now.” 
 
Additionally, many providers spoke of depression screenings being done on the 
same schedule for all veterans, and not necessarily being aware that any extra were being 
done for prenatal or postpartum women. Providers expressed frustration with the lack of a 
formal referral process in place; many noted that women Veterans in need of mental 
health were mentioned to them during conversations with the maternity care coordinator 
or another person conducting perinatal depression screening rather than through a 
standardized referral process.  
Providers also believed they might be missing perinatal patients experiencing 
symptoms when the screenings were done by maternity care coordinators who were too 
overburdened with other duties to conduct routine screens. One provider expressed her 
concerns regarding screening, identifying a lack of training among those conducting the 
screens, and lack of a protocol or standard procedures for referrals for positive screens:  
“The mental health symptom screening measure that they use at our facility is the 
PHQ-2, which I think is pretty inadequate to capture not only depressive 
symptoms but also anxiety, posttraumatic stress, and just other realms of distress 
that may emerge during the perinatal period…and it may be that the maternity 
care coordinator here just doesn’t have a ton of experience or confidence working 
with psychiatric distress.” 
 
There was also uncertainty around screening procedures and standards. Some 
facilities identified routine screens with the Patient Health Questionnaire (PHQ) or 
Edinburgh Postnatal Depression Scale (EPDS), while others were unsure which screening 




whether by primary care providers or maternity care coordinators, or if it was done 
regularly. A few providers noted the lack of MCCs at their facilities, making routine 
screening more challenging due to lack of personnel resources. 
 
Inconsistencies in Treatment Decision-Making 
Providers spoke of the importance of conducting a risk/benefit analysis regarding 
psychotropic medications to determine the best plan of treatment for each individual 
patient; however, no providers identified standard policies, procedures, or protocols for a 
mental health medication risk discussion with their pregnant patients. One provider 
explained: 
“I think every, every medication that the patient is on is evaluated within the 
context of pregnancy. You know, like some things are like just absolutely 
contraindicated. And then there are things that are…like ideally you wouldn’t be 
on but you would perform a risk/benefit ratio, like there’s animal data that shows 
that this could be a problem in pregnancy but…you know you have to sort of 
weigh the risk/benefit ratio, given the patient’s underlying psychiatric condition.” 
 
Providers shared that their patients were receptive to these conversations and 
“trust(ed) the provider to know” about medication safety and associated risks during 
pregnancy. One provider explained in detail the risk/benefit conversation she has with her 
patients, with her patients typically “really open” to her recommendations. Many 
providers noted that medication alone was not enough to treat complex mental health 
issues, especially during pregnancy, and recommended evidence-based therapies for their 
patients. Providers found that having these discussions prior to pregnancy with existing 
patients could lead to “better options” in terms of timing for discontinuation of 




Providers spoke candidly about being respective and supportive of the choices 
their patients ultimately made, as there was wide variability reported around women 
deciding to continue or discontinue antidepressants during pregnancy. Many providers 
noted the influence of societal and cultural pressures to go off medications during 
pregnancy, despite the necessity for some patients. As one provider said: 
“It varies depending on how severe their illness is. I would say the more ill the 
woman is and the more she realizes that she’s likely to get really sick if she goes 
off her medications, the more likely they are to say ‘I’m going to stay on these’. 
The women who haven’t been as sick or don’t have as much insight into how sick 
they’ve been are more likely to say ‘I’m going to go off these’. But there’s 
definitely a societal pressure to go off medications when you’re pregnant. Women 
tend to prioritize the baby over their own mental health.” 
 
Another provider similarly noted that she often finds her patients having anxiety 
about “how to do a good job and follow the rules during pregnancy.”  
One provider, a non-prescriber, commented on the unique experiences of veterans 
as being important to take into account when having a risk/benefit discussion: 
“I always frame it like, ‘if you’d like to talk with a psychiatrist and learn about 
what your options are, would you like that? No pressure, you don’t have to take 
anything if you don’t want to, but at least to give you an idea of why you’re 
feeling really depressed right now…(and) find out what your options are, and 
what the options are that are going to create the least amount of risk for you and 
for your baby…would you like that?’ And if a person says ‘yes I would’, then I’ll 
schedule the appointment. And I really try to frame it that it doesn’t mean you 
have to commit to anything, think of it just as a consultation. And I think that 
really takes the pressure off of the Veteran to feel like they’re going to be pushed 
in one way or the other, to know that they have the freedom to make a choice, and 
I think that’s really important for any of us, but especially with trauma survivors 
and Veterans.” 
 
Similarly, this same provider expressed the necessity for a “gentle” conversation 




“Very often it involves, depending upon the severity of the depression, a 
significant conversation around medication, which can be difficult, particularly if 
they’re breastfeeding and that’s, you know, something that’s personally or 
culturally important to them…Sometimes it’s…a reframing of self-care as being 
important for the care of the infant. You know so often they think that they’re not 
as important, and we talk about how, you know, that their infant relies on them 
entirely for their wellbeing and if they’re not well that that has implications for 
the infant. So sometimes conversations about, you know, in a gentle way, never in 
a way that implies, you know, guilt or shame or anything like that.” 
 
Many of the providers discussed the alerts within VHA patient electronic medical 
records that flag pregnant veterans. They found these clinical alerts to be very helpful in 
facilitating discussions regarding medication use with their patients and other providers. 
This was especially important because many providers spoke about a lack of specific 
psychiatrists or pharmacists within their facility that did medication reviews for pregnant 
veterans on a regular basis.  
 
Lack of Communication with Obstetricians  
When probed about communication with obstetricians, very few providers shared 
experiences with such contact. Many providers stated difficulties in attempting to contact 
obstetricians and felt that even if they reached out to obstetricians they rarely received 
communication back or had difficulty receiving information due to patient privacy 
releases. Some providers recalled experiences of complex patient cases requiring 
communications with the obstetrician, exemplified by one provider who stated that “only 
in more complicated cases have I actually had contact with the obstetrician.” Many 




especially when it came to psychotropic medication use during pregnancy. As one mental 
health provider explained: 
“I don’t necessarily know what the OB is doing, because there’s not real good 
communication when the OB care is farmed out, that’s the biggest problem and 
the biggest barrier I would say…Rarely do I get communication from the 
OBGYN. And a lot of obstetricians are very uncomfortable with mental health 
medications, so I never know how comfortable they are with what I’m doing.” 
 
Many providers spoke of the benefit that having an obstetrician on staff would be for 
their VHA facility. One provider believed the addition of obstetrical care would 
ultimately benefit mental health, as well: 
 
“Our VA (gynecologist) does zero care for pregnant Veterans regarding their 
pregnancy, and so there’s no (obstetrical) care at all provided in house. And so 
just from an emotional standpoint, a Veteran who has to go to multiple different 
hospitals…I think that’s normal for many civilians, but for Veterans I think it 
would be really good for them to have their care at their VA...I think it would just 





Coordination through PC-MHI Teams 
Several providers discussed the availability of PC-MHI models at their facilities. 
This model of care coordination and care personalization for veterans receiving care 
within the VHA was identified by providers as promoting mental health care among 
perinatal women. Despite a lack of coordination with non-VHA providers and 
discussions surrounding a need for greater screening and diagnostic practices, providers 
were in general very positive about their experiences with their VHA colleagues. Many 




being an advantage for coordinated care. Often providers noted “easy access” to women’s 
primary care providers for sharing information regarding patients who may need extra 
care. Many providers shared such experiences: 
“It’s really well coordinated in the women’s clinic here, where mental health is 
co-located in the primary care clinic and there’s monthly team meetings and 
there’s like a lot of chatting, you know, in offices or just around, like ‘hey I want 
to talk to you about somebody who stopped by.’ And so, yeah, I would say that 
there’s a lot of conversation between primary care providers and the mental 
health providers.” 
 
“In general, our clinic works pretty hard on coordinating care between primary 
care and mental health… so there’s a good amount of communication about those 
kinds of things.” 
“Since I work in the integrated women’s clinic, we have very good 
communication, we have a team meeting every week. So that communication with 
their primary care physician here is very good.” 
“If somebody is in distress or is starting, or struggling, (primary care) will refer 
them over to us. And then I try to get in the people who are pregnant or who are 
postpartum very quickly.” 
One provider reported that having access to patient records from the initial pregnancy 
confirmation visit with the veteran’s primary care provider allowed her team to develop a 
plan for screening and treatment initiation: 
"The project that we came up with was any time that the Women Veteran’s 
Program Manager gets alerted to a newly pregnant Veteran…(we) do a brief 
chart review using a sort of checklist of looking for some evidence-based risk 
factors that we’ve identified from the literature. And kind of based on the number 
and severity of the risk factors that we identify in the chart review, we then follow-
up either with information about mental health services, like that’s the lowest 
level intervention is to mail somebody information about mental health services in 
our clinic and what we do, and just like a little bit about kind of things to look out 
for, like postpartum depression and stuff like that, and, you know, stuff about 




do an outreach call and strongly encourage them and sort of provide them with 
some psychoeducation about their risk factors and stuff like that...We’ve (also) 
developed a screening tool for folks that come in for an intake after that process, 
and also a semi structured interview before that."  
 
DISCUSSION 
Our results showed variation across facilities and providers in terms of 
standardized screening and treatment practices; however, coordination between primary 
care and mental health providers was widely reported to be a strong facilitator to 
providing mental health care to perinatal veterans. Mental health treatment is complex 
during the perinatal period and care, especially regarding medication use, and needs to be 
at an individualized case-by-case level. However, certain policies for depression 
screening, referrals to mental health providers for symptomatic veterans, and medication 
review could be better encouraged to improve standardized care across the VHA. Nearly 
40% of the providers we contacted who declined to participate in an interview cited lack 
of caring for pregnant or postpartum veterans although they were identified as providers 
who work with veterans during the perinatal period. This suggests an absence of 
knowledge within sites on which mental health providers are caring for perinatal 
veterans, given the identification of these providers as potential participants.  
During the pregnancy confirmation visit, Handbook 1330.03 specifies a 
psychosocial-risk assessment take place with screening for depression and other 
psychiatric illness, with appropriate referrals made based on the results of this screening 
to confirm diagnosis and begin care. Because veterans must visit the VHA to confirm 




unique opportunity to engage their pregnant patients with mental health care. As veterans 
are a high-risk population for mental health complications in and following pregnancy, 
current recommendations for preventing depression in high risk women suggest 
engagement with therapy even if initial depression screens are negative.85 Previous work 
has shown that integrating perinatal depression care into outpatient obstetric settings is 
feasible, effective, and acceptable54; it is likely that this would also be true with the VHA 
mental health system with better coordination from screening to care. Developing 
protocols to standardize processes for depression screening and timing of screenings 
during pregnancy is an important initial step in creating an integrated system of perinatal 
depression care. 
Wide variation also existed across facilities for medication risk/benefit 
discussions. Providers were unable to identify standards of care for such discussions or 
recommendations for medication use or discontinuation among pregnant veterans. Past 
research has shown that pregnant women prefer providers to lead the discussion and 
decision-making process on medication risks during pregnancy.80 Additionally, pregnant 
women have reported feeling more comfortable with antidepressant use during pregnancy 
after a more in-depth conversation with their provider.92 Previous work in this area has 
shown that in general, women feel that medication use for depression is acceptable during 
pregnancy, but many stop their own depression medication upon pregnancy 
confirmation.79 Other studies have shown that depressed prenatal women often have 




there is greater treatment adherence among patients whose providers offer more 
decisional support.93  
Lack of coordination between mental health providers and offsite obstetricians 
was identified as one of the greatest facility-level barriers to quality depression care. 
Similar to these findings, previous work has shown that systems-level barriers to 
perinatal mental health care include a lack of collaboration and communication between 
obstetrical and mental health providers.94 The VA maternity care coordination guidelines 
mandate a maternity care coordinator (MCC) at each facility who is charged with 
tracking maternal and fetal outcomes, coordinating services for pregnant veterans, and 
coordinating care for comorbid conditions such as depression. However, a substantial 
amount of time is required from MCCs to provide adequate services for pregnant 
veterans. Many of the providers reported part-time MCCs at their facilities, with MCCs 
balancing their primary role within the VHA with the additional work of perinatal care 
coordination. Previous pilot work has found that a centralized, telephone-based maternity 
care coordinator to cover multiple VHA facilities resulted in high patient satisfaction, 
especially with regard to understanding VHA services and benefits. A similar program 
implemented across a greater number of VHA facilities could provide a centralized 
location for depression screening and local referrals.51 
We acknowledge that our study was limited by only including the perspectives of 
VHA mental health providers. Our sample size was relatively small and is not 
representative of all VHA mental health providers. Interviews with maternity care 




health care pregnant and postpartum veterans are receiving. We were limited to the VHA 
sites working with the larger COMFORT study and the perspectives of mental health 
providers at these sites; therefore, these findings cannot be generalized to all VHA 
medical facilities or mental health providers caring for pregnant and postpartum veterans.  
Our study has numerous strengths. We conducted interviews with a sample of 
VHA mental health providers across the US. We utilized a semi-structured interview 
guide for greater flexibility in participant responses. Our providers had many years of 
experience working in the VHA. Additionally, we interviewed a wide variety of 
providers, (including both prescribers and non-prescribers), which gave us a more 
complete picture of the care pregnant and postpartum veterans are receiving.  
 
CONCLUSIONS 
 Mental health providers caring for veterans during and after pregnancy identified 
several areas where care could be improved, notably in screening and referral processes. 
Given the strong internal coordination already in place at many VHA facilities, such as 
through PC-MHI teams, improving access to mental health care for perinatal veterans is 
likely feasible.  
 
IMPLICATIONS FOR PRACTICE AND/OR POLICY 
This study has shown that a refinement to current guidelines to specify standard 
screening tools, screening schedules, and referral processes could potentially engage a 




standard protocols or trainings for medication risk/benefit discussions would also benefit 
both mental health providers and perinatal veterans. Additionally, providers included in 
our study identified several key areas where policy changes, whether at the national VHA 
level or at individual facilities, could be implemented to increase access and ease barriers 












Table 4.1: Number of Interviews Completed and Types of Providers Interviewed by Site 
Site 





Psychiatrist Psychologist LCSW Nurse/Nurse Practitioner Physician 
Durham, North Carolina      4 
New Orleans, Louisiana      4 
Minneapolis, Minnesota      3 
Los Angeles, California      3 
Iowa City, Iowa      3 
Dallas, Texas      2 
Denver, Colorado      2 
Fargo, North Dakota      2 
West Haven, Connecticut      2 
Boston, Massachusetts      2 
Leeds, Massachusetts      2 
Tampa, Florida      2 
Little Rock, Arkansas      1 
Reno, Nevada      1 
 33 
 
*Note: LCSW=licensed clinical social worker; specific roles included Chief of Mental Health for the Women’s 
Health Clinic, Women’s Health Medical Director, Chief of Mental Health, MST Coordinator, primary care 





Table 4.2: Sociodemographic Characteristics of Participants 
Variable Total (n=33) 
Age (years), mean +/- SD 45.1 +/- 9.9 




























Number of years worked with the VA, mean +/- SD 10.2 +/- 7.7 
Number of years worked at current VA, mean +/- SD 8.8 +/- 8.0 








Abbreviations: PhD/PsyD=Doctor of Philosophy/Psychiatry, MD=Medical 
doctor, LCSW=Licensed Clinical Social Worker 
 
Note: Other races included Indian, European American and American Indian, 
Caribbean American, Asian; specific nursing categories included 1 RN, 1 BSN, 






Table 4.3. Theme Groupings & Associated Codes Identified by Providers describing 
Experiences of Mental Health Care Management for Veterans during the Perinatal 
Period
Theme Grouping Associated Codes 
CARE EXPERIENCES 
• Typical timing of mental health care 
• Depression screening 
• Standards of care/guidelines 
TREATMENT EXPERIENCES 
• Medication review during pregnancy 
• Medication risk discussions 
• Medication use during pregnancy 
• Medication discontinuation  
CARE COORDINATION  • Care coordination with other VHA providers 






CHAPTER V: DISCUSSION AND CONCLUSIONS 
 
PURPOSE AND SPECIFIC STUDY QUESTIONS 
 
 Perinatal depression affects a substantial number of women in the general 
population,8–13 and can have long-term consequences on both mothers and infants.15,16 
History of depression is a risk factor for perinatal depression;18 depression is the most 
commonly diagnosed medical condition among all women veterans ages 18-44.22 
Estimates of depression prior to pregnancy in women veterans range from 10-60%, 
suggesting a higher likelihood of pregnant veterans developing depression compared to 
pregnant women in the general population.6,19 Despite these statistics, little work has been 
done in identifying the occurrence of or treatment modalities for perinatal depression in 
veterans. The purpose of this work was to identify the rates and correlates of depression 
symptoms and to understand mental health care utilization and depression management 
during pregnancy in women veterans receiving care within the VHA healthcare system, 
within the context of VA guidelines in Handbook 1330.03.4 Our specific study objectives 
and questions were: 
Aim 1: To examine rates of perinatal depression symptoms in pregnant veterans. 
• What is the prevalence of depression symptoms in a sample of pregnant 
veterans? 
• What proportion of our sample has an EPDS ≥10? 




Aim 2: To evaluate the rate of mental health care treatment utilization during 
pregnancy and to understand the experience and management of depression in a 
sample of pregnant veterans.  
• Are veterans with a past history of depression more likely to utilize mental 
health care, either through psychiatric visits or antidepressant use, during 
pregnancy? 
• What decisions do women veterans make regarding antidepressant use 
during pregnancy? 
• Do pregnant veterans discuss medication risks with their providers to help 
make decisions regarding antidepressant use during pregnancy? 
Aim 3: To explore the experiences of VHA mental health providers within the 
context of policy recommendations for seamless care coordination and treatment 
management for pregnant and postpartum veterans. 
• What is a typical care experience for women veterans with perinatal 
depression?  
• Is care coordination for pregnant and postpartum veterans occurring 
between VHA mental health providers and other VHA providers? Is 
care coordination occurring between VHA mental health providers and 
non-VHA obstetricians? 
• Does care coordination promote consistent care for pregnant and 




• How do providers approach antidepressants and treatment options for 
pregnant and postpartum veterans with depression symptoms? 
SUMMARY OF FINDINGS 
 
In Aims 1 and 2, our analyses utilized survey data from telephone interviews 
conducted with pregnant veterans enrolled in the COMFORT study. In Aim 1, we found 
that 28% of our sample showed depression symptoms (EPDS ≥10) during pregnancy. 
Our final multivariable logistic regression model indicated that veterans having spousal 
or partner support during pregnancy decreased odds of an EPDS ≥10 by 65% compared 
to veterans reporting no spousal or partner support. Veterans reporting being employed 
reduced the odds of an EPDS ≥10 by 60% compared to those reporting being 
unemployed, a homemaker, or a student. A past diagnosis of anxiety, any antidepressant 
use, and history of active duty service all resulted in increased odds of an EPDS ≥10. The 
prevalence of depression in our sample was found to be greater than the high end of 
prevalence estimates in the general pregnant population.8,14 
In Aim 2, we found that in general, rates of care were promising with nearly 70% 
of women veterans with an EPDS ≥10 receiving at least one mental health visit or 
psychotropic prescription during pregnancy. This finding suggests that mental health care 
is available and accessible for pregnant veterans. However, symptomatic women without 
a past diagnosis of depression were less likely to receive care (either mental health visits 
or antidepressant prescriptions) during pregnancy. This highlights the need for depression 




this aim we explored qualitative data collected during the COMFORT pregnancy 
telephone interview on a subset of our sample of pregnant veterans with an EPDS ≥10. 
We identified themes relevant to mental health medication risk discussions with 
providers, use of mental health medications during pregnancy, and discontinuation of 
mental health medications during pregnancy. We found that the experiences of 
depression and mental health treatment during pregnancy varied. Several participants 
reported discontinuing medications after discussions of associated risks with providers; 
however, other participants chose to discontinue medications on their own without a 
risk/benefit discussion with a provider. Many women reported the challenges of 
managing depression during pregnancy without medications, either due to their providers 
requesting they discontinue use or due to their own personal decisions.  
In Aim 3, we utilized data from semi-structured interviews conducted with VHA 
mental health providers. Mental health providers identified an existing gap in diagnosis 
and care for veterans with new onset depression during pregnancy, who may be missed 
by mental health providers if screening and referrals are inadequate to engage 
symptomatic women in treatment. Many mental health providers reported being unsure 
about standard protocols at their facility for screening, assessment/diagnosis, and 
referring pregnant veterans with depression symptoms to counseling and other types of 
care. While mental health providers noted successful care coordination with other VHA 
providers, specifically through PC-MHI teams, coordination or communication with 
obstetricians rarely occurred. Several mental health providers expressed openness to 




illness and assessment of need. Additionally, mental health providers identified areas 
where care could be improved, including in screening and referral processes. As internal 
coordination teams are already in place at many VHA facilities, improving access to 
mental health care via the depression care pathway to improve symptomatology is likely 
feasible.   
IMPLICATIONS 
 
This work is important given the rapid growth in the population of young women 
veterans and the increase in the receipt of maternity care via the VHA system. Our 
findings have the potential to influence VHA facility-level improvements and VA 
policies that enhance prenatal care for women veterans. This study provided an 
opportunity to establish and refine study methods, such as the use of the EPDS screener 
and semi-structured interviewing, to be used in similar veteran populations in future 
research. The findings from this work could be used to form hypotheses and develop 
objectives for intervention studies designed to improve mental health care for pregnant 
veterans. Additionally, we outline several important clinical and policy contributions of 
this work below.  
Clinical Implications 
This work confirms that a substantial proportion of pregnant veterans experience 
depression symptoms during their pregnancies. While many of these women receive 
some form of mental health care from the VHA during pregnancy, this study highlights 




several key risk factors for the development of prenatal depression symptoms. As we 
showed that nearly 1/3 of our sample experienced EPDS scores ≥10, women veterans of 
reproductive age could potentially benefit from preventative therapy and interventions 
targeting perinatal depression awareness, prior to pregnancy onset. During pregnancy, 
medication discussions with providers should include information regarding non-
pharmacologic and pharmacologic treatment options with a balanced risk discussion 
addressing outcomes associated with untreated and treated disease.  
 
Policy Implications 
Our results have the potential to inform policy within the VA. Handbook 1330.03 
was implemented to encourage standardized care for pregnant and postpartum veterans 
through maternity care coordination and targeted care for veterans with comorbid 
conditions such as depression. We found that many mental health providers felt that the 
procedures in place at their facilities for depression screening, diagnosis, and referral to 
treatment could be improved. Routinizing and mandating screening system-wide, along 
with a better standard of procedures for referral and treatment to mental health providers, 
could improve care for veterans in the perinatal period.  
Recommendations for depression screening as outlined in the VA/DoD guidelines 
should become standard across all VHA facilities working with pregnant veterans, with 
screenings conducted with the EPDS or PHQ-995 in the first trimester, third trimester, and 
postpartum for all pregnant women veterans.29 Allotment of resources for a maternity 




and follow-up with pregnant veterans. Additionally, the person conducting depression 
screenings should be trained in a referral process to engage symptomatic women in 
further care as needed.  
Once referrals have been made, mental health providers should have access to 
research and strategies related to treatment planning and medication risk discussions with 
pregnant women. Standardized questions or discussions related to the risks and benefits 
of different types of evidence-based depression treatments, either medications or 
psychotherapy, during pregnancy may help veterans and their providers better 
communicate and determine the best course of action. Education for mental health 
providers may also increase their awareness and comfort with treating pregnant veterans 
with depression. Previous studies have shown that within the context of depression 
management in a primary care location, shared goal setting between patients and 
providers, patient education, and more patient follow-up lead to greater improvement in 
patient health.96 Improved discussions within the VHA have the potential to lead to more 
individualized treatment and management plans for depression during pregnancy as well 
as encourage long-term treatment adherence for women veterans.  
When possible, early pregnancy is the ideal time to identify treatment strategies 
for depression due to changing medication recommendations over the perinatal period 
and new barriers after delivery.11,56 As veterans must have a VHA appointment to 
confirm pregnancy, requiring screening for depression during this visit, identifying risk 
factors, and proactively providing referrals to mental health providers could help reduce 




screeners such as the EPDS can be administered and scored within minutes, these 
suggestions are reasonable. As we found that women without a history of depression 
were less likely to receive treatment for depression symptoms during pregnancy, 
integrating a system such as that developed by the MCPAP for Moms study may benefit 
both new onset and existing cases of depression.97,98 This system includes trainings for 
providers and staff, real-time psychiatric consultations, and linkages with care and 
support resources that would occur during the initial pregnancy screening appointment. 
Access to these resources while the veteran is onsite could encourage more fluid care 
between veterans and mental health providers, especially for veterans without a previous 
relationship with mental health at their VHA facility. 
Recently, policymakers have encouraged engagement with mental health care 
prior to the development of depression symptoms. The USPSTF issued a draft 
recommendation in the fall of 2018 that clinicians “provide or refer pregnant and 
postpartum women who are at increased risk of perinatal depression to counseling 
interventions.”85 As research indicates that counseling interventions can help improve 
perinatal depression outcomes, the USPSTF recommends identifying at-risk women, such 
as women veterans, for perinatal depression counseling early, effectively engaging them 
with mental health care prior to the presence of symptoms. This recommendation could 
assuage some of the existing barriers to care during pregnancy, such as stigmas 
surrounding seeking mental health care, lack of knowledge about depression and 




during pregnancy or postpartum,57 if a relationship with a mental health provider is 
established as a standard of practice within the VHA maternity care program.  
STRENGTHS 
 This dissertation has numerous strengths. For Aims 1 and 2, we included samples 
of pregnant veterans from VHA facilities in geographically distinct regions of the US. 
Our analysis of pregnant veterans included a large sample of participants. The 
COMFORT survey was designed to collect information on a multitude of topics, giving 
us an adequate pool of potential correlates to perinatal depression to examine. To identify 
depression symptoms, we utilized the EPDS which has been previously validated for use 
in pregnant populations.38 Additionally, we were able to link to electronic health records 
and VA administrative files to obtain prescription and healthcare utilization data which 
greatly enriched our COMFORT survey data. We were also able to calculate sensitivity 
and specificity using information from electronic health records to gain a better 
understanding of the difference between the self-reported responses in COMFORT and 
VA medical record information. In addition, our use of a mixed methods approach in 
Aim 2 to conduct both quantitative and qualitative data analyses provided a variety of 
perspectives on depression symptom management and mental health care during 
pregnancy. Our method of collecting qualitative data via semi-structured interviews gave 
participants flexibility in their responses and allowed conversations to flow naturally for 
more variability in discussions.  
 In Aim 3, we conducted interviews with a sample of mental health providers from 




participant from every COMFORT site, and two or more mental health providers from 12 
out of the 14 COMFORT sites included (86%). Of the eligible mental health providers 
we contacted, overall participation rate was high, with 73% of the participants we invited 
to participate completing an interview. The mental health providers we interviewed had 
an average of ten years experience working in the VHA, suggesting our sample was 
knowledgeable about their work within the VA system and with veterans. Furthermore, 
we interviewed a wide variety of mental health providers, including both prescribers and 
non-prescribers, which gave us a more complete picture of the mental health care 
pregnant and postpartum veterans are receiving. Our use of semi-structured interviews 
allowed the conversations to flow more naturally, giving mental health providers the 
opportunity to discuss thoughts or ideas not necessarily included in the interview guide 
but nonetheless important to the topic at hand.  
LIMITATIONS 
 We acknowledge that this dissertation also has limitations. In Aims 1 and 2, we 
utilized results from an EPDS that was only conducted once during pregnancy, and at a 
varying gestational age among our participants. Likewise, we did not control for the 
gestational age at administration of EPDS in our analyses which may influence EPDS 
scores/depression symptoms. Additionally, EPDS cannot be used as a diagnosis tool, only 
as a means of identifying depression symptomology. With this in mind, we may have 
underestimated our rates of depression symptoms in this sample. As the overall 
COMFORT study was designed to examine many facets of pregnancy and pregnancy 




depression would participate less than healthier women leading to non-response bias 
from more depressed pregnant veterans. Similarly, women who participated may not 
have felt comfortable answering the EPDS questions accurately due to social desirability 
bias if they were concerned about their potential negative responses. This type of 
response bias would also underestimate our depression symptomology findings. Our use 
of a telephone survey to obtain data from the pregnant women in our study also 
introduces inherent biases. Recall bias may occur when responding to questions regarding 
past medical experiences. However, the EPDS utilizes a short 7-day recall period and our 
inclusion of electronic health data mitigates some of these concerns.  
In Aim 2, it is possible that women started taking an antidepressant or seeing a 
mental health provider following the prenatal interview, which ranged from 4-39 weeks 
gestation in our sample, and thus would not be captured in the self-report responses. Our 
analyses assumed that antidepressant prescriptions were used as prescribed; however, we 
may have included antidepressant prescriptions filled in very early pregnancy which may 
have been stopped upon pregnancy confirmation, potentially inflating our estimates of 
antidepressant use. Along these lines, we limited our focus by only including 
antidepressant prescriptions in our analysis. We chose to focus on depression 
symptomology and therefore antidepressant use for this dissertation; however, this 
potentially excludes a wide range of other mental health medications our participants may 
have been taking. Contradicting this limitation, our survey included broad questions 
regarding self-reported receipt of mental health care rather than solely focusing on 




conditions other than depression, potentially biasing our estimates of receipt of mental 
health counseling. Likewise, mental health visit utilization captured by EHR data was not 
specific to depression care. However, given our emphasis on women with symptomatic 
EPDS scores, it is likely that any mental health care they were receiving included 
discussions on and/or treatment for depression. 
We were unable to identify mental health care received during pregnancy from a 
non-VHA provider, which may explain our low specificity calculations as presented in 
Aim 2. Given that most discordant cases were due to women self-reporting depression 
where it was shown absent in the EHR, this could potentially be due to diagnoses outside 
of VHA care (either before the veteran was eligible VHA care or made by a provider 
outside of the VHA system). Finally, our findings are likely not generalizable to a 
broader population outside of English-speaking pregnant veterans receiving their care 
within the VA medical system.  
In Aim 3, we only included the perspectives of mental health providers and were 
unable to include data from maternity care coordinators, primary care physicians, or non-
VA obstetricians. We acknowledge that this limits our scope of understanding of the care 
pregnant veterans receive at VHA sites. Our sample size was relatively small and is not 
representative of all VHA mental health providers. Additionally, we were limited to the 
VHA sites working with the larger COMFORT study and the perspectives of mental 
health providers at these sites; therefore, these findings cannot be generalized to all VHA 
medical facilities or mental health providers caring for pregnant and postpartum veterans.  





This research adds to the sparse existing literature on perinatal depression and 
treatment among pregnant veterans and highlights the need for additional research. Future 
studies are needed to better examine the existing rate and timing of depression screenings 
for pregnant veterans at VHA sites, to clarify the depression screening, diagnosis, and 
treatment referral process for pregnant veterans, and to more accurately quantify the rate 
of antidepressant use and medication adherence during pregnancy. Additional research 
focusing on treatment utilization patterns among pregnant veterans will provide greater 
insight into the types and prevalence of treatment strategies most often used during 
pregnancy. This work illuminates what is still needed among pregnant veterans 
experiencing depression symptoms, especially for at-risk women without a history of 
depression who may be more likely to slip through existing cracks on the 
screening/diagnosis/referral to care pathway.  
The VHA is a unique healthcare system, that given proper resources, could set up 
an optimal process of depression screening, management, and treatment for perinatal 
veterans. As discernable through the issuance of Handbook 1330.03,4 care for pregnant 
and postpartum veterans is a priority within the VA. This work and future research may 
help to inform revised perinatal depression screening and assessment guidelines and 
encourage a streamlined system to efficiently diagnose and link perinatal women veterans 




APPENDICES FOR CHAPTER II 
 
Appendix 2.1: Distribution of EPDS Items by Total Score 
 
EPDS Item 





Have you been able to laugh and see the funny side of things? 0.74 0.72 0.07 0.27 
0, As much as you always could  56 39.4% 332 92.5% 
1, Not quite so much now 68 47.9% 24 6.7% 
2, Definitely not so much now 14 9.9% 1 0.3% 
3, Not at all 3 2.1% 0 0.0% 
Have you looked forward to things with enjoyment? 0.97 0.89 0.14 0.40 
0, As much as you ever did 49 34.5% 312 86.9% 
1, Rather less than you used to 56 39.4% 43 12.0% 
2, Definitely less than you used to 27 19.0% 3 0.8% 
3, Hardly at all 9 6.3% 1 0.3% 
Have you blamed yourself unnecessarily when things went 
wrong? 1.96 0.97 0.68 0.87 
0, Not at all 17 12.0% 200 55.7% 
1, Not very often 18 12.7% 81 22.6% 
2, Yes, some of the time 61 43.0% 68 18.9% 
3, Yes, most of the time 46 32.4% 9 2.5% 
Have you felt anxious or worried for no good reason? 2.48 0.64 0.89 1.00 
0, Not at all 3 2.1% 177 49.3% 
1, Hardly ever 2 1.4% 64 17.8% 
2, Yes, sometimes 61 43.0% 95 26.5% 
3, Yes, very often 76 53.5% 22 6.1% 
Have you felt scared or panicky for no good reason? 1.62 0.70 0.34 0.66 
0, No, not at all 18 12.7% 276 76.9% 
1, No, not much 18 12.7% 45 12.5% 
2, Yes, sometimes 106 74.6% 38 10.6% 
Have things been getting on top of you? 1.73 0.74 0.47 0.68 
0, No, you have been coping as well as ever 9 6.3% 225 62.7% 
1, No, most of the time you coped quite well 36 25.4% 97 27.0% 
2, Yes, sometimes you haven't been coping as well as usual 82 57.7% 33 9.2% 
3, Yes, most of the time you have not been able to cope 15 10.6% 2 0.6% 
Have you been so unhappy that you have had difficulty 
sleeping? 1.71 1.05 0.28 0.64 




1, Not very often 28 19.7% 48 13.4% 
2, Yes, sometimes 51 35.9% 18 5.0% 
3, Yes, most of the time 37 26.1% 6 1.7% 
Have you felt sad or miserable? 1.71 0.81 0.32 0.55 
0, No, never 10 7.0% 258 71.9% 
1, Only occasionally 43 30.3% 87 24.2% 
2, Yes, quite often 67 47.2% 12 3.3% 
3, Yes, most of the time 22 15.5% 1 0.3% 
Have you been so unhappy that you have been crying? 1.42 0.84 0.23 0.46 
0, No, never 14 9.9% 282 78.6% 
1, Only occasionally 73 51.4% 72 20.1% 
2, Yes, quite often 37 26.1% 3 0.8% 
3, Yes, most of the time 18 12.7% 1 0.3% 
Has the thought of harming yourself occurred to you? 0.41 0.74 0.01 0.12 
0, Never 104 73.2% 357 99.4% 
1, Hardly ever 19 13.4% 1 0.3% 
2, Sometimes 18 12.7% 1 0.3% 




Appendix 2.2: Multiple Imputation Methods 
Regression models were run using a complete case analysis which included just 
over 80% of our sample. Most of the missing were for two variables, marital status and 
service connected disability. We assumed that both of these variables would be MCAR or 
MAR and not missing based on presence of depression symptoms. However, when 
comparing missingness, there was a statistically significant difference between the 
proportion missing marital status by group (15.5% for EPDS>=10 vs. 6.7% for 
EPDS<10, p=0.002) and for those responding to the question regarding past use of 
antidepressants (0.0% for EPDS>=10 vs. 3.1% for EPDS<10, p=0.03).  
We used PROC MI to impute values for all variables used in our final models 
(p<0.05 in bivariate analyses). This included marital status (n=46 missing), service-
connected disability (n=28 missing), past use of antidepressants (n=11 missing), report of 
military sexual trauma (n=9 missing), and employment (n=1 missing). Additionally, we 
looked for potential auxiliary variables to include in the imputation calculations, but there 
were few that were correlated (at a level of r>0.40) with our final variables. Several MI 
calculations were then run: 
1. Given our arbitrary missing patterns, we began by using a Markov chain Monte 
Carlo (MCMC) method with a fully conditional specification (FCS) that assumes 
the existence of a joint distribution for all variables to impute a monotone pattern, 





2. Using the above imputed values, we ran a full regression model including all 
variables and used MIANALYZE to pool the data and examine diagnostics; we 
then ran a second model using backward selection as we did in our main analysis 
and then used MIANALYZE again on this output. 








3) Ratitch B, Lipkovich I, O’Kelly M. Combining Analysis Results from Multiply 
Imputed Categorical Data. PharmaSUG. 2013; 1–19. Available: 
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Appendix 2.3: Results with Any Mental Health, Depression Excluded    
  
Logistic Model 
including all variables 
p<0.05 in bivariate 
analyses 
Logistic Model with 
Backward Selection 
GLIMMIX - cluster 
on site w/ variables 
from final MV model 
MI Model 1: FCS 
with Rounded Values, 
Full Logistic Model* 
MI Model 2: FCS 
with Rounded Values, 
Backward Selection 








































(Yes vs. No) 






























(Yes vs. No) 
2.78 1.15 5.43 3.11 1.61 5.99 3.63 2.10 6.26 2.99 1.70 5.26 2.99 1.72 5.22 
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(Married vs. 
Not Married) 
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(Yes vs. No) 
1.12 0.64 1.94             1.64 1.00 2.67 1.76 1.09 2.84 
Ever 
Treatment for 
Drug Abuse or 
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(Yes vs. No) 



















variables p<0.05 in 
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Logistic Model with 
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GLIMMIX - cluster 
on site w/ variables 
from final MV 
model 
MI Model 1: FCS 
with Rounded 
Values, Full Logistic 
Model* 












































(Yes vs. No) 






























(Yes vs. No) 













(Yes vs. No) 






























variables p<0.05 in 
bivariate analyses 
Logistic Model with 
Backward Selection 
GLIMMIX - cluster 
on site w/ variables 
from final MV 
model 
MI Model 1: FCS 
with Rounded 
Values, Full Logistic 
Model* 












































(Yes vs. No) 






























(Yes vs. No) 













(Yes vs. No) 









(Yes vs. No) 









(Yes vs. No) 















variables p<0.05 in 
bivariate analyses 
Logistic Model with 
Backward Selection 
GLIMMIX - cluster 
on site w/ variables 
from final MV 
model 
MI Model 1: FCS 
with Rounded 
Values, Full Logistic 
Model* 












































(Yes vs. No) 











1.71 0.95 3.07 1.91 1.08 3.37 1.62 1.00 2.60 1.48 0.89 2.46       
Ever Anxiety 
Diagnosis 
(Yes vs. No) 










(Yes vs. No) 













(Yes vs. No) 











(Yes vs. No) 







(Yes vs. No) 
1.41 0.68 2.93             1.51 0.80 2.84 1.84 1.00 3.39 
Ever PTSD 
Diagnosis 
(Yes vs. No) 




(Yes vs. No) 




(Yes vs. No) 















variables p<0.05 in 
bivariate analyses 
Logistic Model with 
Backward Selection 
GLIMMIX - cluster 
on site w/ variables 
from final MV 
model 
MI Model 1: FCS 
with Rounded 
Values, Full Logistic 
Model* 












































(Yes vs. No) 











1.58 0.89 2.83             1.37 0.83 2.26       
Ever Anxiety 
Diagnosis 
(Yes vs. No) 























(Yes vs. No) 
2.00 0.82 4.88 2.43 1.03 5.78 2.05 
0.97 4.34 











(Yes vs. No) 






(Yes vs. No) 




(Yes vs. No) 
1.25 0.62 2.53             1.45 0.76 2.75       
Ever Bipolar 
Diagnosis 
(Yes vs. No) 









APPENDICES FOR CHAPTER III 
Appendix 3.1: List of Stop Codes used in Identifying Mental Health Visits during 
Prepregnancy and Pregnancy 
Mental Health Care 
Stop Codes* 
143, 165, 207, 213, 292, 501, 502, 503, 504, 505, 506, 510, 
511, 515, 516, 520, 521, 522, 524, 525, 526, 527, 528, 529, 
530, 531, 532, 535, 536, 537, 538, 540, 541, 542, 546, 550, 
551, 552, 553, 554, 557, 558, 559, 561, 562, 563, 564, 571, 
572, 573, 574, 575, 576, 577, 578, 579, 580, 581, 589, 590 
 
*Does not include visits for alcohol, drug, or other substance abuse treatment.  
 
 
Appendix 3.2: List of Antidepressants* Included in Definition of Antidepressant 




citalopram, Celexa, Cipramil, escitalopram, Lexapro, Cipralex, 
Seroplex, Lexamil, fluoxetine, Prozac, Sarafem, Symbyax, 








amitriptyline, Elavil, Endep, clomipramine, Anafranil, doxepin, 
Adapin, Sinequan, imipramine, Tofranil, trimipramine, Surmontil, 




isocarboxazid, Marplan, moclobemide, Aurorix, Manerix, phenelzine, 
Nardil, selegiline, Eldepryl, Emsam, tranylcypromine, Parnate 
Other antidepressants** 
mianserin, Tolvon, mirtazapine, Remeron, Avanza, Zispin, 
bupropion, Wellbutrin, Zyban, tianeptine, Stablon, Coaxil, Tatinol, 
agomelatine, Valdoxan, Melitor, Thymanax 
 
*Note: Search terms included generic and brand names as listed.; **Noradrenergic and specific 
serotonergic antidepressants (NASSA); norepinephrine-dopamine reuptake inhibitors (NDRI); 
bupropion; selective serotonin reuptake enhancers (SSRE); tianeptine; norepinephrine-




Appendix 3.3: Semi-Structured Interview Guide 
 
Next, I would like to ask you some more details regarding your care. I know that we 
discussed these points earlier, but any additional thoughts or comments that you could 
offer would be appreciated. Again, your comments will remain anonymous.  
 
1. To the best of your knowledge, has there been any communication between your 
VHA providers (medical or mental health) and obstetrical providers during your 
pregnancy?  
a. If yes, what was the nature of this communication? 
2. Have you experienced any mental health concerns or depression during your 
pregnancy?  
a. Has the VHA helped you address these needs? If so, how?  
b. Has your OB helped you address these needs? If so, how? 
3. Were you taking any medications in the months prior to, or currently, during your 
pregnancy? This could be for mental health concerns, pain management, or other 
health conditions. 
a. Is your OB aware of all of these medications? 
4. Did you make any changes to your mental health medications once you became 
pregnant? If so, why? 
5. Did the MH provider discuss with you the risks associated with medications and 
pregnancy? 
a. Did your VA provider?  
b. Did your OB? 
 
If the Veteran answered “Yes” to the MST questions: 
 
6. You had previously indicated you had experienced MST. Could you talk more 
about this experience? Specifically, has your experience with MST shaped (or 
influenced) your views or experiences with pregnancy or childbirth? 





Appendix 3.4: Time Periods of Mental Health Care/Antidepressant Prescription Identification from VA Electronic 




Appendix 3.5: Results from Sensitivity Analyses Varying the Pregnancy Time Window (at 200, 280, and 300 Days) 
 
Appendix 3.5.1: Care Utilization among Veterans with Depressive Symptoms Before & During Pregnancy, 200, 280, 
and 300 Day Comparisons with VA Corporate Data Warehouse (CDW) Electronic Health Record Data (n=135) 
 200-day window 280-day window* 300-day window 
Mental Health visits, mean +/- SD (range)    
Pre-pregnancy  4.0 +/- 6.6 (0-33) 5.3 +/- 9.1 (0-45) 5.7 +/- 9.7 (0-52) 
Pregnancy 4.5 +/- 7.2 (0-43) 6.1 +/- 9.4 (0-54) 6.6 +/- 10.0 (0-57) 
Any Mental Health visits, n (%)    
Pre-pregnancy  76 (56.3) 79 (58.5) 79 (58.5) 
Pregnancy  82 (60.7) 91 (67.4) 93 (68.9) 
Antidepressant Prescription, n (%)    
Pre-pregnancy  57 (42.2) 57 (42.2) 67 (49.6) 
Pregnancy  29 (21.5) 50 (37.0) 54 (40.0) 
Any VHA Mental Health Care during Pregnancy (1+ mental 
health visit or antidepressant prescription in VA CDW EHR) 
(N, %) 
86 (63.7) 99 (73.3) 99 (73.3) 
 
*Main analysis results. 
 
Time period definitions: 
200 days: Pre-pregnancy=(Newborn date of birth-200)-200; Pregnancy=Newborn date of birth-200 
280 days: Pre-pregnancy=(Newborn date of birth-280)-280; Pregnancy=Newborn date of birth-280 
300 days: Pre-pregnancy=(Newborn date of birth-300)-300; Pregnancy=Newborn date of birth-300 
 







Appendix 3.5.2: Care Utilization among Veterans with Depressive Symptoms Before & During Pregnancy, 200 Day and 
280 Day Comparisons with VA Corporate Data Warehouse (CDW) Electronic Health Record Data (n=135) 
 200-day window 280-day window* P-value** 
Mental Health visits, mean +/- SD (range)    
Pre-pregnancy  4.0 +/- 6.6 (0-33) 5.3 +/- 9.1 (0-45) 0.01 
Pregnancy 4.5 +/- 7.2 (0-43) 6.1 +/- 9.4 (0-54) <.0001 
Any Mental Health visits, n (%)    
Pre-pregnancy  76 (56.3) 79 (58.5) 0.56 
Pregnancy  82 (60.7) 91 (67.4) 0.003 
Antidepressant Prescription, n (%)    
Pre-pregnancy  57 (42.2) 57 (42.2) - 
Pregnancy  29 (21.5) 50 (37.0) <.0001 
Any VHA Mental Health Care during Pregnancy (1+ mental 
health visit or antidepressant prescription in VA CDW EHR) 
(N, %) 
86 (63.7) 99 (73.3) 0.0003 
 
*Main analysis results. 
**Wilcoxon signed rank test for continuous comparisons; McNemar’s test for comparisons of proportions. 
 
Time period definitions: 
200 days: Pre-pregnancy=(Newborn date of birth-200)-200; Pregnancy=Newborn date of birth-200 
280 days: Pre-pregnancy=(Newborn date of birth-280)-280; Pregnancy=Newborn date of birth-280 
300 days: Pre-pregnancy=(Newborn date of birth-300)-300; Pregnancy=Newborn date of birth-300 
 






Appendix 3.5.3: Care Utilization among Veterans with Depressive Symptoms Before & During Pregnancy, 280 Day and 
300 Day Comparisons with VA Corporate Data Warehouse (CDW) Electronic Health Record Data (n=135) 
 280-day window* 300-day window P-value** 
Mental Health visits, mean +/- SD (range)    
Pre-pregnancy  5.3 +/- 9.1 (0-45) 5.7 +/- 9.7 (0-52) 0.01 
Pregnancy 6.1 +/- 9.4 (0-54) 6.6 +/- 10.0 (0-57) <.0001 
Any Mental Health visits, n (%)    
Pre-pregnancy  79 (58.5) 79 (58.5) - 
Pregnancy  91 (67.4) 93 (68.9) 0.16 
Antidepressant Prescription, n (%)    
Pre-pregnancy  57 (42.2) 67 (49.6) 0.01 
Pregnancy  50 (37.0) 54 (40.0) 0.05 
Any VHA Mental Health Care during Pregnancy (1+ mental 
health visit or antidepressant prescription in VA CDW EHR) 
(N, %) 
99 (73.3) 99 (73.3) - 
 
*Main analysis results. 
**Wilcoxon signed rank test for continuous comparisons; McNemar’s test for comparisons of proportions. 
 
Time period definitions: 
200 days: Pre-pregnancy=(Newborn date of birth-200)-200; Pregnancy=Newborn date of birth-200 
280 days: Pre-pregnancy=(Newborn date of birth-280)-280; Pregnancy=Newborn date of birth-280 
300 days: Pre-pregnancy=(Newborn date of birth-300)-300; Pregnancy=Newborn date of birth-300 
 






APPENDICES FOR CHAPTER IV 
 
Appendix 4.1. Semi-Structured Interview Guide 
1. To start, could you describe your current position in the VA? What are your 
responsibilities? How long have you been there? Are you situated directly in the 
women’s clinic or elsewhere? Do you primarily work in the main hospital or are you at a 
CBOC?  
2. I am specifically interested in mental health care during the perinatal period. How often 
do you work with women before, during, or after pregnancy?  
a. Prompt: When do you typically first see women Veterans? Could you provide an 
example of a common situation working with women during the perinatal time?  
3. In your experience, do most pregnant Veterans leave the VA entirely during their 
pregnancies, or do some Veterans continue to receive VA care for certain conditions? 
Can you tell me more about the types of conditions that require ongoing care? 
a. Prompt: In general, how are women Veterans doing during and after pregnancy? 
What are some of the issues or problems they are struggling with?  
b. Prompt: In general, can you identify any resources that women Veterans need, 
but don’t have, in their first year of motherhood? 
c. Prompt: When working with postpartum Veterans, do you have any standard 
questions you ask to assess any unmet needs regarding parenting or specific 
needs of their infants? 
d. Prompt: If a woman were struggling with parenting issues or issues related to her 
infant, would you know what resources to offer them or where to refer them for 
help? 
4. Regarding medication use during pregnancy, are you aware of anyone at your facility 
who routinely reviews medications for women who are newly pregnant or during 
pregnancy? Do you know if there is any type of safety planning done with pregnant 
women on medication use in the perinatal period?  
5. I am also interested in learning more about care coordination for pregnant Veterans.  
a. Prompt: To what degree do you communicate with a woman Veteran’s 
obstetrician? In general, do you have any contact with that person during the 
pregnancy?  
b. Prompt: Is there any communication among VA providers during a woman’s 
pregnancy with regard to her medical conditions as they relate to pregnancy? 
6. Are you aware of any VA guidelines or protocols that discuss care for pregnant women? 
Do you have a general approach to caring for pregnant women, such as a specific 




a. Prompt: Are you aware of any VA resources or training for mental health 
providers on treating perinatal depression?  
i. Were you able to attend the 2016 Women’s Mental Health Mini-
Residency? If so, did you attend sessions regarding perinatal mental 
health issues?  
ii. Did you participate in the Women’s Mental Health Prescriber 
Teleconference Series? Was pregnancy discussed during these meetings?  
iii. Are you aware of the Women’s Health Services reproductive mental 
health training curriculum?  
b. Prompt: Does your facility conduct routine depression screening for pregnant 
Veterans that receive care at your VA? Are you aware of any formal VA 
guidelines on depression screening? 
7. In your opinion, does your facility provide sufficient resources and staff to support 
women during the perinatal period?  
a. Prompt: In general, have you felt that your facility is supportive of pregnancy 
care and/or maternity care? Can you tell me why you have found them 
supportive, or not? Can you give me specific examples of their support, or lack 
thereof? 
b. Prompt: In your perspective, is there anything that could be improved in terms of 
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